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NOW ELDEPRYL IS INDICATED FOR FIRST LINE THERAPY. 
Now you can do more than deal with the disability of Parkinson's disease. You can delay 
it with Eldepryl first line. o In newly diagnosed patients. Eldepryl can significantly 
retard the worsening of symptoms2.3 and delay the need for levodopa therapy. 2.•.s o In fact. 
Eldepryl can delay the onset of disability and thereby prolong functional life by as much 
as one yearY o As well. Eldepryl 
appears to have a remarkable safety 
profile. It has been generally well-
tolerated with few side effects.•·6•7 
o So when you see patients with 
Parkinson's disease . prescribe 
Eldepryl first line. It's their first 
line of defence against the pro-
gression of disability. 
selegiline hydrochloride 
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The practice of draping 
crosses near coastal margins to 
warn passing ships of the 
presence of epidemic infections 
has existed in Europe and 
South America for many 
centuries. The cover depicts a 
mixed media painting of a 
cross on the seashore at Lima, 
Peru from a photograph taken 
during the Peruvian cholera 
epidemic, part of the seventh 
cholera pandemic, which 
claimed 500,000 lives world-
wide in 1991-92. 
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GUIDELINES 
The purpose of the U.W.O. Medical Journal is 
to provide a single forum for original a rticles 
based on clinical or research medicine of topical or 
historic relevance . Since the readership of the 
Journal is interdisciplinary, articles published will 
attempt to reflect the wide range of medical 
disciplines. The Journal will consider empirical, 
theoretical, and research reviews. Book reviews 
will also be considered. The Journal reserves the 
right to refuse articles that do not comply with the 
Journal's publication criteria. 
MANUSCRIPT SUBMISSIO N: Each submission 
mus t include three (3) copies of the full 
manuscript PRIOR TO the submission deadline. 
Late submissions will not be accepted for 
publication. Authors are expected to submit the 
final revised version of the manuscript on 3.5" 
computer diskette along with three (3) copies of 
the manuscript (the Journal prefers Apple 
Macintosh"' Microsoft"' Word or Wordperfect"' 5.1). 
All figures must be camera-ready and artwork 
must be black and white. 
MANUSCRIPT PREPARATIO N: Manus c ripts 
submitted should be set with one inch margins 
and typed single-spaced. Original research and 
review articles should have an abstract that clearly 
states the relevance of the article to the medical 
discipline being reported on in no more than 150 
words. This dimension should be elaborated upon 
in the introduction . Original research a r ticles 
should have experimental methods, results, and 
discussion sections that follow the introduction. 
Results and discussion sections may be combined 
if appropriate . The discussion section should be 
concise and focus primarily on the findings being 
presented and their important implications. 
Authors should rely on articles or information 
published in recognized journals and sources. 
References should be listed in numerical order 
and within the text in the following format: 
1. Manev H ., Favaron M., Guidotti A., & Costa E. 
Delayed increase of Ca ++ influx elicited by 
glutamate: role in neuronal death. Malec. 
Pharmacal. 36:106-12 (1989). 
(With 3 or more authors, either all authors may be 
listed or the 1st author followed by et al.) 
The Journal reserves the right to edit articles to 
correct grammatical or stylistic errors. 
TO AUTHORS 
AUTH O RSHIP: All medical students and 
members of the Faculty of Medicine of U.W.O. are 
invited to submit manuscripts for publication. 
Medical students are certainly encouraged to 
collaborate with medical staff who specialize in 
the medical sub-discipline being reported on. 
Manuscripts will also be considered from medical 
faculty (including interns and residents) from 
universities and medical institutions other than 
U.W.O. 
M O DES O F C O MMUNICATIO N: Authors 
should submit along with their manuscripts a 
cover letter including a return address, telephone 
number, and fax number (where available) . The 
final revised version of the manuscript on 3.5" 
computer diskette should be sent (with (3) 
photocopies of the manuscript) to: 
The Editors 
U. W.O. Medical Journal 
Health Sciences Building; 
University of Western Ontario 
London, Ontario N6A-5Cl 
Proud to support 
the U.W.O. 
Medical Journal 
THE 
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Journal reflects solely the views and opinions of the authors of the material printed and not necessarily the editorial 
staff of the Journal. 
©All material published in the U. WO. Medical Journal is copywright protected-no section of the U. W.O. Medical 
Journal may be reproduced without the expressed written permission of the editorial board of the Journal. 
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HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) 
TRANSMISSIBILITY AND THE LAW 
Legal issues related to human immunodeficiency virus-1 (HIV-1) and acquired immunodeficiency syndrome (AIDS) 
are evolving more rapidly, perhaps, than any other subject in recent Western law history. Among these issues is the 
rela tion of AIDS to the criminal code-specifically disease transmission as an offence. Of particular interest in this 
regard is what constitutes an illegal act of disease transmission and what retributive measures exis t for such acts. 
Analysis of two cases in which individuals were accused of committing criminal acts related to HIV-1 transmission will 
reveal that existing laws are insufficient to deal with AIDS-related legal matters. 
Case 1 
R. v. Ssenyonga (April 30, 1993), Doc 1560 (Ont. Gen. Div.).1 
Offences: Aggravated sexual assault; consent. Accused [of] infec ting complainants with HTV-1. 
Decision: Acquitted; courts rejecting arguments of consent, fraud, and public policy. 
The accused, knowing he was infec ted with HIV-1 and without telling this to the three complainants, engaged in sexual 
intercourse with them, thus exposing them to the risk of HN-1 infec tion, which they subsequently contracted. The accused 
motioned for a directed verdict of acquittal. This motion was granted based on the ground that each of the three complainants freely 
and volun tarily engaged in sexual intercourse with the accused without the use of a condom . The court upheld that although the 
complainants may not have consented neither to transmission of HIV-1 , nor even to that risk, the evidence was incontestable that 
they did consent to the application of fo rce inherent in the acts of sexual intercourse; this force was not in itself excessive or 
dangerous. Furthermore, since the complainants were under absolutely no misapprehension as to the nature of the acts in which 
they were engaging, there was no evidence of fraud. Ultimately, since section 265(1)(a) of the criminal code was designed to control 
the non-consensual direct or indirect application of force by one person to another, and not to prevent HN-1 transmission among 
the body politic, the Crown's public policy arguments could therefore not prevail) 
Case 2 
R. v. Thornton (August 14, 1989), O.R. (3rd) 480, 42 O.A.C. 206, 3 C. R. (4th) 381 , [1 991] C.C. L. 3659, affi rmed (june 4, 1993), 
Doc. 22312 (S.S.C. ).2 
Offences: Cau sing bodily harm by criminal negligence. Accused lofl endangering lives of public by knowingly donating 
contaminated blood contributing an unlawful act. 
Decision: Convicted; 15 months imprisonment. 
The accused was infected with HN-1 and tested positive on two occasions for AIDS. Despite this, he donated blood to the Red 
Cross. The accused appealed the decision on the basis that his conduct was not an offence, that it was not proven to have endangered 
anyone, and that he lacked the guilty mind. The appeal was rejected. The common law upheld that every person was to refrain from 
potentially malicious conduct. According to the court, the accused personally knew the danger to which the public was subjected 
consequent to his donation of contaminated blood and thus had the requisite guilhj mind. In light of the potential serious hann and 
damage to the lives and health of the public, the accused was properly convicted.2 
These cases are characterized by similarities and differences-some are obvious and some are not. In both cases, 
notwithstanding knowledge of being infected with HIV-1 , the accused engaged in baleful activities. Despite the 
parellelism of these acts, one individual was convicted and one was acquitted . In law, for conviction of a crime to be 
maintained, the commission of an offence must contain two components, proven beyond a rea onable doubt. These 
components are mens rea (guilty mind) and actus reus (guilty act). In addition, mens rea and actus reus must exist in the 
background of the offence charged. Taken alone, each case appears to involve acts with both mens rea and actus reus. But 
this is not true when the offences are measured against the charges; this is where weaknesses in the law in relation to 
AlDS become punctuated. 
o specific legislation which exists is designed to deal with offences related to HIV-1 infection and AIDS. Thus, 
such offences must be categorized under existing sections of the criminal code. Ssenyonga was charged with aggravated 
sexual assault pertaining to sections 265(1)(a) and subsequently 273 of the criminal code. Section 265(1)(a) states that: 
A person commits an assault when without the consent of another person, he applies force intentionally to 
that other person directly or indirectly.3 
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Section 273 of the criminal code states that: 
Every one commits an aggravated sexual assault who, in committing a sexual assault, wounds, maims, 
disfigures, or endangers the (1) life of the complainant. (2) Every one who commits an aggravated sexual 
assault is guilty of an indictable offence and liable to imprisonment for life.3 
Under the letter of the law, therefore, the accused was found not guilty of assault and thus of aggravated sexual assault. 
Thornton, however, was charged with criminal negligence causing bodily harm pertaining to section 221 of the criminal 
code. This section states that: 
Every one who by criminal negligence causes bodily harm to another person is guilty of an indictable offence 
and liable to imprisonment for a term not exceeding 10 years.3 
Thus, the accused was properly convicted. Had Ssenyonga been charged under s.221, he too might have been convicted. 
A further example of how existing laws are insufficient to deal with AIDS-related offences is based on retributive 
measures. In regard to case 1, the accused was acquitted and thus received no penalty. In regard to case 2, the accused 
received 15 months imprisonment; there were no identifiable victims. Had there been any victims, the accused's 
sentence may have increased but only to the maximum 10 years. Although AIDS is a fatal disease, it is not immediately 
so. Furtheron, although there is a section of the criminal code designed to deal with criminal negligence causing death 
(s.220) with a potential liability of life imprisonment, section 227 of the criminal code would likely prevent an AIDS-
related offence from being categorized under s. 220. Section 227 of the criminal code refers to death within one year and 
one day: 
o person commits culpable homicide or the offence of causing the death of a person by criminal 
negligence ... unless the death occurs within one year and one day from the time of the occurrence of the last 
event by means of which the person caused or contributed to the cause of death.3 
Thus, qualifiers such as s.227 preclude existing laws from exacting just punishment. 
Thus, within the context of the criminal code as it exists today, current laws are inappropriate and improperly 
utilized for unlawfaul acts of HIV-1 transmission. In the cases described, two points are clear. First, the offences 
committed are remarkably similar-an individual knowingly infected with HIV-1 transmitted or attempted to transmit 
the disease, or risk thereof, to innocent, unassuming people. Second, neither section of the criminal code under which 
the accused individuals' were charged appear sufficiently equipped to provide for due course of law. In case 1, the 
accused was charged with aggravated sexual assault, possibly because of the potential maximum penalty of life 
imprisonment, but the charge was inappropriate for the offence. In case 2, the accused was charged with causing bodily 
harm, not death, by criminal negligence; the charge was bodily harm perhaps because of the potential leniency of the 
penalty, and because although AIDS is fatal, it isn't immediately so (at least not within one year and one day). 
Clearly, the capability to transmit HIV-1 infection represents a danger to health and life. Conspicuous by its absence 
is a specific set of laws designed to accommodate AIDS-related offences, especially the unlawful commission of HIV-1 
transmission. These laws will have to strike a balance between the civil rights of the HIV-1-infected population and the 
uninfected population-a difficult task since the AIDS population already suffers from discrimination and is unlikely to 
seek testing or help from public agencies unless reassured that they will be neither further ostracized nor have liberties 
removed. 
I would like to thank Ross and Anne and the entire Journal staff for helping to produce this fine issue, which 
features infectious diseases. Be sure to read Stitches In Time- it's guaranteed to make you smile. And please take a 
moment to read A Note to Our Readers on page 10. Enjoy! 
8 
1 Canadian Current Law. July 30, number 7 (1993). Case Law Digest 6998. 
2 Canadian Current Law. July 30, number 7 (1993). Case Law Digest 7000. 
3 Criminal Code of Canada. R.S.C. 1993. 
Jeffrey rrolitsky, :Meds '94 
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Inequities Of Gender Discrimination 
Recently I attended a continuing medical education 
conference entitled "Gender Inequities in the 
Classroom." The objective of this conference was to 
increase awareness of gender discrimination. However, 
the ensuing discussion used exaggerated examples of 
gender differences in a futile attempt to explore the 
issue of gender discrimination . These examples 
included issues such as the ratio of female to male 
medical school admission applications and alcohol 
consumption patterns at all-female parties. I was 
angered by these ridiculous examples and the overt 
discrimination created by a discussion of gender 
differences. 
Gender discrimination refers to the ability to 
distinguish between men and women. This 'rightful ' 
form of discrimination involves acknowledgment of the 
basic features that distinguish both sexes. Gender 
discrimination may also be defined as unfair treatment 
based on a person's gender. The prejudicial basis of this 
latter form of discrimination makes it 'wrongful'. This 
'wrongful ' form of discrimination deserves attention 
and analysis in an effort to reduce its prevalence in 
society. 
Acknowledging basic features that distinguish one 
gender from another may create greater acceptance and 
understanding among men and women . Attempts to 
magnify these differences, however, will serve only to 
further alienate members of each gender from one 
another. For example, an all-female party organized to 
rally s upport against overt gender discrimination 
merely perpetuates it by intentionally excluding one sex 
from such an event. 
A large proportion of efforts to reduce the incidence 
of 'wrongful' discrimination find ba sis with the 
apparently trivial differences between men and women. 
Yet men and women do not adopt the same societal roles 
and should be treated differently accordingly. Essential to 
the continued effort to decrease 'wrongful' discrimination 
is the confirmation that 'wrongful' discrimination stems 
from prejudice and dislike, not anatomical and societal 
characteristics. The continual analysis of the basic gender 
differences between men and women will trivialize the 
entire effort to eliminate 'wrongful' discrimination and 
will ultimately pit the sexes against each other ad 
nauseum. 
!Anne Silas , Meds •94 
!Associate 'Editor 
Business Quarterly and The UWO Medical Journal: 
Are We Poor Cousins? 
I learned a few weeks ago that The University of 
Western Ontario Business School publishes an extremely 
well respected and well known serial, Business Quarterly 
(BQ). The status of BQ in the field of business manage-
ment may be comparable to that of the New England 
Journal in the field of Medicine. BQ is edited by a retired 
business professor on a part time contract and employs a 
full time staff of two. 
The original Business School journal was started in 
1932, and was managed entirely by students. The earliest 
copies of The UWO Medical Journal (UWOMJ) also date 
from about that time. A major difference between the two 
publications is that the UWOMJ is still managed by 
students. BQ is an ancillary unit of the University, like 
Food Services and the Book Store, while the UWOMJ is a 
subaccount of the Hippocratic Council. BQ's yearly 
budget is about one million dollars; that of the UWOMJ is 
around $20,000. BQ has a subscription circulation of 
about 10,000 at a cost of $39 per year; the UWOMJ has a 
circulation of approximately 2000 and a subscription fee 
of $17 per year, however, most of the readers are 
unfortunately not subscribers. Further, BQ represents a 
professional business school whose reputation is among 
the best in North America, established, in part, on the 
strength of the popularity and esteem of their serial. On 
the other hand, UWOMJ represents a professional school 
whose reputation is possibly the best in Ontario. 
The difference in the historical development of the 
two publications has been the degree of faculty 
involvement. From the beginning, BQ has operated with 
support from Faculty members in the form of an advisory 
council, and subsequently, a consulting editor. 
Eventually the Dean of the School took financial 
responsibility for the publication and, only five years ago, 
appointed the present Editor, who accepted the challenge 
of making BQ self-supporting. The UWO Medical 
Journal, meanwhile, has carried on with a new Editor 
every few years and consequently a new vision, a new 
quality ethic and a new policy, for better or for worse. We 
need a wider subscription base, a greater sense of pride 
and greater Faculty involvement, including the Dean's 
Office. If the experience of our cousins at the School of 
Business is any indication, this is one opportunity the 
School of Medicine can't afford to pass up. 
~oss Mantel, Meds '95 
!Associate 'E.ditor 
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e UW O :Medical Journal is 
rrently in its Gyd year of 
publication . 'Tfie Joumal fias 
undergone many cfianges over tfie past 
62 years-some for beHer, some for 
worse. 1Juring tfie first 45 years or 
so , tfie Journal was strong and 
consistently good ; during tfie 
subsequent IS years , tfie Jo urnal 
suffered from a decline in interest , 
faculty support , and consequently 
quality. 'Tfiis declin e was truly 
unfortunate. 
'Tfie University of Western 
Ontario 'Faculty of :Medicine is fiigfily 
respected, nationwide and beyond, for 
a variety of reasons . 'ffiese reasons 
include undergraduate and graduate 
medical education , clinical practice, 
and scientific researcfi. '10 tfiose of us 
wfio are involved witfi tfie Journal, tfie 
UWO :Medical Journal sfiould be 
anotfier unique aspect of tfie University 
of Western Ontario 'Faculty of 
:Medicine wfiicfi stands out and 
adequately parallels tfie otfier efforts of 
tfie 'Faculty. Since September I99 I , 
tfie Journal fias progressed toward tfiis 
goal. 
'Tfiis is now tfie tfiird consecutive 
year tfiat tfie Journal fias experienced 
improvements and increased interest. 
One need merely to loofi. at tfie Journal 
to appreciate its attractive appearance. 
'Tfie body of tfie Jo urnal is similarity 
better as well, witfi a feature section for 
eacfi issue, and a more diverse range of 
topics , including 'Faculty :News , 
general articles , fiumour, and 
education. 'ffie Jo urnal fia s also 
improved in ways tfiat aren 't so 
obvious-an excellent publisfiing 
company, guaranteed income from 
advertising , and many fiou rs from a 
fiard-worli.i~j] Journal staff. (See 
'Editorial Staff, page J ) 
Yrn ancillary component of tfie 
'Editorial Staff is tfie Yrdvisory Council. 
•Tfie Council, wfiicfi is composed of 
botfi 'Faculty members and medical 
lr @ 
students, was designed and created just 
over one year ago in order to ensure tfie 
maintenance of Journal quality over 
time. 'Tfie creation of tfie Council was a 
large step forward for tfie Journal. 
'Faculty support of tfie Journal fias 
come not only tfirough tfie formation of 
tfie Yrdvisory Council, but tfirougfi 
subscriptions as well. 'ffie income 
generated tfirougfi advertising accounts 
for a large percentage of Journal 
expenses-b ut not all! So , in an 
aHempt to generate jurtfier revenue, tfie 
Journal staff and Yrdvisory Council 
decided to initiate a subscription drive 
targeting 'Faculty members. 'Tfiere 
fiave been many positive responders, a 
few negative responders, and a large 
number of non-responders. 
Some readers fiav e sfiown 
resentment toward tfie subscription 
drive eitfier for fiaving been asfi.ed to 
pay a fee fo r sometfiin,9 tfiat was never 
requested, or for merely being botfiered. 
'ffie Journal sincerely regrets any ill-
will generated because of tfie 
subscription drive. 
'ffie Journal is asli.ing 'Faculty 
members to sfiow tfieir committment to 
R uired R~ding 
throughout 
your career 
For subscription 
information 
call: (416) 596-5981 
tfie Journal in tfie form of a I? 
subscription because we believe tfiat tfie 
current Journal is sometfiing tfie 
'Faculty of :Medicine can not only be 
proud of, but can benefit from as well. 
Yrnd we fiope we can count on your 
support in tfiis manner. '10 demonstrate 
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CORNER: 
NEW 
DEAN ' S 
FACILITIES 
PART 
FOR THE 
EXAM I I 
L.M.C.C. 
I f you have had a chance to drop in on the new Learning Resource Centre lately you may have noticed 
a little office off the main lobby that is a 
beehive of activity. It is our new 
standardized patient office. Thanks to 
startup funding from the Medical 
Council of Canada, we have been able 
to hire Linda Ladner as the co-
ordinator for this new teaching 
resource. She is currently involved in 
our first big standardized patient 
project which will be the Part ll exam 
of the Medical Council. 
As most trainees know, in order to 
get a Licensure of the Medical Council 
of Canada (L.M.C.C.), candidates must 
pass Part I of the Medical Council of 
Canada Qualifying Exam at the end of 
Medical School, complete a year of 
post graduate clinical training, and 
then successfully complete part ll of 
the exam. The first run of the Part ll 
was last year in Calgary and Toronto 
(although pilots had been run before 
that) . This year, since more provinces 
require the new L.M.C.C. credential, 
more centres will be running the exam. 
We will be joining six other sites, 
U.B.C., U. of Calgary, U. of Ottawa, U. 
of Toronto, Sherbrooke, and Dalhousie, 
to run the exam simultaneously on the 
weekend of October 30 and 31. 
The exam is in the objective 
structured clinical evaluation (O.S.C.E.) 
format. It will be composed of ten, ten-
minute patient stations and ten couplet 
stations. The couplet stations will be 
composed of a five minute patient 
"encounter" followed by a five minute 
question response time called a "post 
encounter probe" or ''PEP'' station for 
short. Each of the patient stations will 
have a trained, standardized, patient 
programmed with a story or set of 
signs and symptoms. The candidates 
will have a "hint" as to the patient's 
problems prior to entering the room 
but will have to carry on from there in 
the allotted time. An examiner will sit 
in each room as well and macl< the 
candidate on her or his performance. 
When the buzzer sounds, the encounter 
must stop and the trainee moves to the 
next room in the style of the old ''bell 
ringer" exams that most of us 
remember from Meds and preMeds. 
Linda's job is to recruit and train 
the patients according to the contract 
laid down by the Medical Council. 
This means "auditioning", then 
assigning cases appropriately (you 
can't have healthy 22-year-olds playing 
asthmatic senior citizens), and then 
coaching and rehearsing and refining 
their role playing till it truly becomes 
standardized. Station number six must 
look exactly the same to a candidate in 
London, as it looked to a candidate in 
Vancouver or Halifax. We have had 
excellent cooperation from people from 
all walks of life for this project and 
many have had experience in amateur 
theatre so their portrayals should be 
very lifelike. 
As you might imagine, security for 
such an exam is important. The exam 
takes four and a half hours (including a 
half hour intermission) and runs twice 
over on Saturday and twice on Sunday 
so a total of four cohorts of forty each 
can "write" here in London. The 
Saturday morning exam and afternoon 
exam are identical but the afternoon 
cohort will register and be closeted 
before the morning group are finished 
so there should be no communication 
between the groups. The Sunday 
exam is a different exam but equivalent 
in terms of difficulty. You might think 
that the time zone differences might 
prove to be a security problem, 
however, by the time the Dalhousie 
morning group get out of the exam the 
Vancouver afternoon group will 
already have gone in. The large 
number of examiners and 
standardized patients involved are all 
By Jim Silcox, M.D., Meds '67 
Assistant Dean, Student & Faculty Affairs. 
sworn to secrecy as well. 
If Linda looks a bit frazzled the 
week of the exam bear with her. The 
logistics of getting our groups of 
candidates, physician examiners, and 
standardized patients parked, 
registered, fed, watered, deregistered 
and finally out of the building will rival 
the efforts of Cecil B. deMille when he 
filmed his mob scenes for the Ten 
Commandments. Nevertheless, as of 
this writing all is going well We have 
a specialized site staff of about twenty, 
plus the resources and amenities of St. 
Joseph's Health Centre to thank for the 
smooth progress to date. 
Within ten days of the Part II 
exam, Linda will be at it again, helping 
Dr. Rieder run another O.S.C.E. for the 
exit exam of the clerkship. She will 
have little time to rest on her laurels! 
In fact, now that she is established, it is 
our hope that departments will use her 
services more and more as time goes 
by. Teaching in a Problem Based 
Learning format or in Clinical Methods 
can be significantly enhanced if there is 
a patient for students to work with. 
We envision the day when course 
coordinators will be able to call her and 
"order" patients with certain 
programmed signs and symptoms for 
use in a teaching clinic for a specified 
time and place. This "off the shelf" 
approach could have applications in all 
Health Science faculties, and indeed in 
other programs like social work and 
education. In time her office and 
position can evolve into a faculty wide 
resource. Visionaries have even 
suggested that this service could 
extend into the community where we 
might help agencies like the Police or 
Fire Departments train personnel to 
deal with the public. If we sound 
excited and enthusiastic it is because 
we are! Drop in sometime when you 
are in the Learning Resource Centre to 
see how things are going. n 
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CLASS REPORTS 
Me d's 94 
THE S.A.P. REPORT 
by Anne Silas, Justin Amann, 
& Jeffrey Politsky 
JP:Well guys, clerkship is nearly 
over. In fact, by the time our trusty 
fans read this report we'll each be 
off in our own elective world. 
JA (beginning to sing): Look's like 
we made it, .. . 
AS (cringing): Uggh. Just cuz 
you're tall doesn't give you the right 
to sing. 
JA: Alright then, ye of one foot 
below, let us peruse our minds for 
remnants of clerkship experiences 
gone by. 
AS: Failing that, we'll just make it 
up! Jeff, you're up-what's your 
personal best? 
JP: Well, there's actually two. But I'll 
tell the second one as a nice segue 
into Debbie P's most ernbarassing 
moment. 
JA: So then, tell us. 
JP: 'Twas a dreary, solemn night. 
The wind howled at the moon 
(ea rlier in the day the sun also 
howled at the moon). Sharp cracks 
of rain were whipped against the 
hospi tal windows with a 
tremendous thrust. 
AS: Good Grief. What a shrnooze. 
JP (ignoring A.S.-he's good at that 
now): The chief surgical resident 
handed me the pager- my very first 
time. Boy, I thought (my thoughts 
were shallow)! I'm not just a clerk 
anymore, now I'm a clerk with a 
pager! Not soon after, I received my 
first call: 
'Mr. H. has a fever of 38.7. He's 
6 hours post-op,' the nurse said. 
'Hmmrn,' I answered (it was all 
I could think oO. 1 just thought 
I'd let you know,' she stated. 'Of 
course, thank you ,' I replied 
quickly, and hung up. 
-FEVER , FEVER-OMEGOD-
FEVER. What do I do? Look up the 
ca uses-too many- holy s_-now 
what? I know, I'll get a doctor, a real 
one, someone with knowledge- grey 
hair, stethoscope, and an unstained lab 
coa t . Where docto r? Wh ere doctor? 
Hmmm , the O.R., that's it, after all, the 
poor sod's post-op. Look, there's Dr. 
Wood, he likes me(??). 
'Dr. Wood, Dr. Wood,' I cried. 
'Oh hi Jeff, how are you?' 'Dr. 
Wood? I need a Dr.' ' Well , 
what's wrong Jeff?' he said 
soothingly. ' I just got my first 
page-a patient has a fever-
38.7!!' I exclaimed. 'Oh dear,' he 
said with a grin, 'what do you 
think caused it?' he asked. 
THINK? THINK! NOW?! Can't think, 
brain gone, Ug, Ug. 
'I'm not sure Dr. Wood, but he 
just had an operation,' I 
answered. 'Hrnrnrn. Well Jeff, 
what does the patient look like, 
is he in pain?' 
PATIENT? LOOK LIKE? PAIN? 
Ohhhh! The Patient! I should examine 
the patient! You stooopid idiot! You 
forgot to see the patient! 
'The patient was vague, sir, but 
I'll go back and get the straight 
goods,' I managed to squeak 
out . 'Good thinking Jeff, and 
don ' t forget to rule out the 
causes of post-op fever. If you're 
still unsure, consider talking to 
the surgeon (why bother me, 
clerk!), he said reassuringly. 
Post-op fever! So that's it. 
I then proceeded back up to 4 NW 
after reading some text, examined 
the patient, and informed the nurse 
that this patient's temperature 
would likely dissipate over time 
and respond to some tylenol. About 
two hours later, I got another call 
from the same floor about the same 
patient: 
'Mr. H . is in pain, his wound 
has broken open, what should 
we do?' the nurse asked. 
OPEN?! He's dehisced? ! OMEGOD-
Doctor , Get a Doctor . I know , Dr. 
Wood ... 
JA: What a horrible experience! Is 
Dr. Wood okay? 
JP:Very funny . How ' bout you 
Anne? 
AS: Moi? Well , one of my worst 
experiences carne on a quiet day in 
the Paeds ernerg. I was working 
with Jeff P. and Dr. Reider-they 
were both looking for someone to 
bug, I mean something to do. I was 
filing my nails when, suddenly, I 
got a phone call. It was a guy named 
Dan, a lonely respiratory therapist 
working at the south street campus. 
He said he remembered me from 
my surgery rotation. 
'Hi! It's Dan! 'Member me?' he 
asked . 'No! ' I replied . ' I'm a 
respiratory therapist; I'm at 
south s treet . Are you busy? ' 
'Yep! ' I answered, not wanting 
to prolong thi s. 'Oh! Well , I 
thought maybe we might get 
together; I could come over 
there if you want-we could 
brea the into the same bag. ' he 
sounded pathetic . 'Gee, Dan, 
I' m awfully busy right now 
(yeah, right!!); this isn' t a good 
time for me .' I sounded off. 
'Okay, there 's always 
tomorrow-is Jackie there?' 
I then proceeded to recount the 
conversation to Jeff . Jeff then 
announced to Dr. Reider that Dan, 
the respiratory man, had just asked 
me, Anne, out for breakfast, to share 
two scoops of raisins in a package of 
Kellogg's Raisin Bran. That' s all I 
heard for the rest of the afternoon-
Dan and Anne and two scoops of 
raisins in a package of Kellogg's 
Raisin Bran. 
JP (smiling & blo cking h is 
privates): Sorry, we were bored. But 
tell me, how did the date end? 
AS: Swine! Okay, Justin, you're 
turn. 
JA: Actually, rather than dispel 
rumours of my upright and 
steadfast performance during 
clerkship, I prefer to live vicariously 
and tell about other peoples' 
blunders and mishaps. 
JP: Fine with us Justin! Why don' t 
you regail us with the yarn about 
Debbie and Dr. Maxwell's crotch? I 
think I've told it to you in sufficient 
detail. 
JA: Indeed! This will be a pleasure. 
As the story goes, it was a Friday 
before Chistrnas, late in the 
afternoon. Dr. Maxwell, decked in 
surgical greens, was lecturing to a 
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group of surgery clerks about 
dissecting aneurysms. I believe, Jeff, 
that you were one of those clerks. 
JP: Oui! C' est vrai. 
JA: As the lecture progressed, 
Debbie's neck began to feel sore. We 
know this to be true because her 
head was reposed downward, at a 
rather peculiar angle, obviously to 
gain relief from the pain she was 
feeling (heaven forbid that it may be 
another, less virtuous, reason). Little 
did Deb know (???), though, that 
her positioning was distracting the 
grand puba. After 5 minutes, or so, 
Dr. Maxwell finally spoke up : 
'(Looking down at his unit) Excuse 
me, Debbie, but is there something 
wrong with my crotch, because you 
can' t seem to take your eyes off of 
it! ' Poor Deb, she was beet red-
laughter was hard-absolute 
hysteria for at least 10 minutes . 
Anyway, just thought we'd record 
this for Deb's sake. Nobody really 
knows why she was staring at him 
that way. 
JP: Sounds suspiscious. 
AS: Even more suspiscious is the 
clerk who sold his soul by paying to 
be off call. 'Nough said. 
JA: We can't forget about Ken and 
Harry. On surgery, Ken's resident 
accidently set a patient on fire, 
which Ken promptly put out. Then, 
clerk Ken got chastized for 
contaminating the sterile field. And 
good ol' Harry. He'll be a researcher 
I tell you. 
AS: Whadya mean? 
JA: Harry wanted to know if 
naloxone really is an opiate 
antagonist. So, he found a patient 
who was particularly morphine-
sensitive for his study. He then gave 
him just the right dosage of 
morphine! He followed this with 
some Narcan (that's thinking on 
your feet!) and successfully reversed 
the morphine effect. Now, he ' s 
known in medical circles as 'the 
narc. ' 
AS: Please, let us not forget the 
story of the clerk and the wrong 
orifice . One day on an emerg 
rotation, a green clerk was sent in to 
a female patients' room, a .k.a . 
' young Dr. _____ , ' as he was 
introduced by the resident. 'Dr. 
__ is going to do a rectal exam in 
order to feel your mass; go ahead 
Dr.' After a couple of minutes, our 
young clerk/Or. looked up and said 
to the resident, 'I'm sorry, I can't 
seem to palpate the mass.' The 
patient quickly intervened at this 
point, ' Perhaps that's because 
you're not in my rectum!! ' The 
resident then left the room, since he 
couldn't control his laughter in 
public. 
JP: Poor chap. Oh well, that's all we 
have to say this time 'round. Look 
out for the final S.A.P. Report ever, 
in the next issue. For those of you 
who are wondering, yes, the JJ 
Report is no more; the new model 
(the S.A.P. Report) is apparently 
50% more invasive. Q 
Me d s I 9 5 
by Jamie McNabb 
W hat to say, what to say, what to say? I guess we could welcome one 
another back from summer 
vacation, but by the time this has 
gone to press, that little formality 
will have taken care of itself ad 
nauseum. So, let's just forget that 
one, shall we? I think it would be 
better if I just forged ahead and 
relayed all the juicy little tid-bits 
that have been cooked up over the 
first couple of months of 3rd year. 
Well, nothing has happened. Zip. 
Zero. Nada. Alright, there were a 
couple of pubs, Ocktoberfest, maybe 
a few private get togethers of 6 or 8 
people eating spinach dip and 
exchanging gossip, but there didn't 
seem to be any one big blow-out 
where everyone got together and 
whooped it up as a class. Maybe 
that's what this space in the Journal 
should address this time around. 
The more I think about this, the 
more I've seen it coming. It is not a 
phenomenon that has reared its 
ugly head just for our class alone. 
We're not, as a group, such bad 
folks that we should be singled out 
for such a fate. I'm sure it happens 
to every class at some point along 
the line, and I guess now it' s our 
tum. 
We' re not the Class of ' 95 
anymore . I think it ' s more 
appropriate that we be called "the 
Multiple Sub-Classes of '95." We've 
all found those around us with 
whom we feel most comfortable . 
These are the ones we call when we 
want to go out, or hang out with 
when we want company. I guess it' s 
only natural. But inherent in this 
segregatory process is the fact that 
not only do we choose who we want 
to be with, but we also identify 
those we want to be without. 
Remember the first da y of 
Medicine when we were all milling 
about outside AuditoriumA, 
tempering our own excitement with 
the awkward nature of being 
thrown together with a bunch of 
near total strangers? I guess this 
whole process started then; how, 
I'm not so sure. Maybe it was the 
way we looked ("Will you look at 
the nose on that guy?") or how we 
dressed ("Can you believe it' s after 
Labour Day and she's still wearing 
white?"), but no matter, we were all 
doing it. We liked certain things 
about some, and disliked things 
about others, allowing only a few 
Got a 
hot one? 
\I/ 
We can handle it. 
When yuu·re '" ' rush. 
c:arrw tD us. 8ecaJse 
jOU"I besuemgo< 
quolily quocldy. - 10 
----Praclltly located 
iD theRVPuk 
outside the UCC 
;CI/Pf 
CliTIIl 
8 a.m. - 8 p.m. 
Mon. Fri. 
9 a.m. - 4 p.m. 
Saturday 
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exchanges between the "in" and the 
"out" piles. 
Don' t get me wrong. I don' t think 
that we should start looking now for 
a ninety-six bedroom bungalow with 
a lovely backya rd on a major bus 
route so we ca n all live as one big 
happy family, that' unrealistic. After 
all , most leases don' t come up until 
April or May. I also don' t think we 
should get together once a month at 
a pre-arranged time and place for a 
group hu g . But ma y be we could 
remember once in a while that, like 
it or not, we are all linked by a 
common bond -we're the ones who 
will graduate as physicians in 1995, 
come hell or high water. All of us 
face simila r obstacles, especially in 
thi , our clerkship year, and we all 
have to get by them. On that basis 
alone we have more in common than 
we might at first have thought. 
So when you ' re going about your 
bu iness this yea r, and you're just 
fini hing a day where you've felt like 
a com pl ete fool every time yo u 
offered an answer, and you pass by 
one of your classmates on your way 
to Kavorkian's office, s top a nd 
chat ... briefly. Maybe we' ll find that 
the "Out" pile is a little smaller than 
we once thought. Q 
Me d 5 
by jay Nathanson 
H ere We Go Again 
Welcome back. I hope everyone 
had a fabulous summer and is 
refreshed, recharged and ready to 
learn. It sure is nice not to be known 
as the " first yea rs" an y more . 
Speaking of firs t year, ours ended 
with a blast. As the rest of U.W.O. 
was leaving for home, Med s '96 
(having a couple more months to go) 
brought in the summer with a "hot-
tub" party at Kirk's. With that out of 
our sys tem, we bared down for 
exa m s . Finally, the interminable 
Phase I ended, and we bid adieu at 
the bar-b-que and piflata party hosted 
by Drs . Anderson and Garcia . The 
revelry began again with the first 
week of September, as sleepy-eyed 
members of Med '97 (a nd a few 
dedicated Meds '96ers) found their 
way to the UH patio for what was to 
be the mother of all orientation weeks. 
Congratulations to Tara and Marcie, 
who certainly outdid themselves in 
running such a great orientation that 
all of us wished that we were in first 
year again (Well, maybe not. But they 
were pretty dam do e). I don' t know, 
but Fanshawe will never be the same 
now that we actually all know each 
other- not that it s topped u from 
showing Meds '97 how to party. 
Anyway, good luck to all in the 
new year, and a special welcome to 
Meds '97. Remember, if we could do 
it, so can you. 
P.S. Congratulations to Lisa 
Klassen (nee Rupke) on her marriage 
and to Mike Hor ey, Joe Kim, and 
Steve Gallant on their engagements 
this summer. n 
Me d 5 
by Angelo Mikrogianakis, 
Heather McMulkin , and ]apheth Noah 
Accept them and they will come .. .. Accept them and they will come." The ghostly voice 
haunted the Admissions Committee 
continuously. What could it mean? 
Why could only they hear it? The 
entire group had become confused 
and frightened. 
The voices became louder and 
more persis tent as the hot d ays of 
summer began. On July 9th the voices 
reached a deafening crescendo. Then, 
suddenly, the y disappeared as 
quickly and mysteriously as they had 
begun . There was no ex planation, 
everyone was just happy it had 
ended. 
Beginning on July 11th, the joy 
and celebration spread through 
certain homes across the country . 
Plans were made, suitcases packed, 
transportation a rranged and 
accommodations reserved. In early 
September the migration began . 
Ninety-six people were on their way 
to London and U.W.O .. They did not 
know what awaited them there or 
what the future would bring. 
It was not until the morning 
hours of September 8th that both their 
Facul t y News 
and th e Admissions Committee's 
questions were answered. They had 
all come in search of a dream!. .. to 
form the "Class of Dreams", U.W.O. 
Meds '97. 
The theme of thi s yea r ' 
orientation was particularly inviting, 
"Go hard ... or go home." The Dean's 
BBQ was a relaxing way to spend our 
first evening together. Some of the 
most common phrases heard were: 
"You're from New Brunswick too!?", 
"Which one is Angelo?" , "Why did 
they give us RED hats?", and "I'm o 
glad that I d o n't ha ve to cook 
tonight" . An interesting event some of 
us attended wa the Western vs 
Guelph football game. We had to 
wear our Meds '97 T-shirts and hats 
to get in . Our s u gges tion to next 
year's orientation committee is not to 
give out red and white hats to new 
s tudent when Wes tern is playing 
Guelph because those are Guelph 
University football colours! Yes, we 
were cool. 
Apparently our class consists of 
38 females, 56 males and two cross 
dresser ! At the Fanshawe Park picnic 
we had a large turnout but were 
unable to get enough gi rls to 
participate in the traditional "boat 
race". Luckily, Mike and Angelo/lina 
quickly volunteered to take the girls' 
places and willingly donned bras, 
makeup and creative new hair style . 
Med '97 maintained su ch a high 
party a tmos phere throughout 
September that the entire class lost 
their body defense mechanisms and 
got the flu! Since we have classmates 
from Toronto, Ottawa, Montreal, 
Fredericton, Halifax, London, rural 
Alberta and Vancouver, the origin of 
thi s flu is an epidemiologist's 
nightmare! 
During preceptor day some of us 
were initiated in various fields of 
medicine and a few of us got to 
appreciate our own ignorance in 
surgery. 
In essence, the orientation was 
memorable, the Faculty was great and 
most importantly, Meds '96 deserves 
to be commended for their excellent 
work. Thanks also to the upper year 
classes, whose orientation expertise 
was probably transduced from Meds 
' 94 through '95 to Meds '96 via 
neuromuscular or gap junctions. Q 
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HIPPOCRATIC COUNCIL 
WHAT'S BEEN 
THE REST OF 
HAPPENING 
CANADA AND 
IN ONTARIO, 
BEYOND .•• 
This past year has seen much activity within the health care forum resulting from changes 
in government policies and 
agendas. 
Social Contract 
By now, most people are familiar 
with the Ontario government' s 
social contract talks which were 
directed at deficit reduction. When 
the dust settled in August, the 
OMA and the provincial 
government signed and ratified an 
interim agreement that will last 
until early 1996. Based on this 
agreement, total OHIP expenditures 
will be reduced over a three-year 
term. Expenditures in excess of the 
limit will be the responsibility of 
the profession. The government 
has already taken steps to reduce 
overall expenditures (tightening 
eligibility criteria for health 
insurance) . The OMA has also 
recently advised physicians to 
reduce their individual billings by 
5% for the current fiscal year. This 
is in an attempt to prevent the need 
for "clawbacks." In addition, OHIP 
will be holding back 4 .8 % of 
billings which will be returned to 
those physicians who at the end of 
their fiscal year, are successful at 
reducing billings. 
In an attempt to improve 
physician resource management, 
physician supply will be stabilized 
over the next three years. During 
this period, out-of-province 
physicians without formal Ontario 
medical training will not be eligible 
to bill OHIP for services. In 
addition, International Medical 
Graduates wishing to be licensed in 
Ontario will require certification 
(by the CFPC or RCPSC) as well as 
at lea s t one year of Ontario 
postgraduate training. Certifi-
cation of all new Ontario graduates 
will continue to be the prerequisite 
to licensure. The government has 
promised to develop further plans 
to promote voluntary retirement 
and to enhance physician 
distribution to underserviced areas. 
Many other initiatives are being 
developed to improve physician 
resource management. 
In addition, a number of 
management changes are being 
initiated to address issues such as 
health-card fraud, public 
education, delisting, and third-
party services.l 
Other Ontario Business 
The Clinical Clerkship stipend, 
once a part of the Ministry of 
Health's Clinical Education Budget, 
has been formally eliminated. Only 
those students who are currently 
completing their clinical clerkship 
will be entitled to a smaller 
percentage of the original stipend. 
The Council of Ontario 
Universities released a discussion 
paper in August. This paper 
proposed increases of 30 % to 
tuition by 1995-96 in most 
undergraduate programs. As well, 
second-entry professional pro-
grams, such as medicine and law 
are to ha ve tuition realigned to 
double the rate for undergraduate 
arts and science students. The 
rationale for the latter include 
proportionally smaller tuition fee 
contributions to total costs of 
programs such as medicine and 
dentistry, as well as the potential 
earnings of graduates from such 
programs. 
U.S. Training Visas 
Students who are interested in 
completing their residency training 
south of the border should know 
that the doors are closing rapidly. 
In order to receive a }1-VISA 
required for training, students 
require sponsorship letters from 
the government of Canada. Such a 
by Ambrose Au, Meds '95, V.P. External. 
letter will be granted to medical 
graduates only for the following 
reasons: if the province in which 
the candidate intends to seek 
licensure can show that the training 
is consistent with the province's 
existing physician resource plan; if 
the candidate has obtained pre-
arranged employment or return-in-
service commitment in Canada; or 
if the candidate is licensed and 
undertaking further clinical 
training in his field of practice . 
Under Ontario's current physician 
resource management plan, 
graduates are u nable to seek 
training in the U.S. 
The alternative H-1B-VISA for 
postgraduate training requires all 
candidates to have passed all three 
steps of the USMLE. This visa is 
currently under review in the U.S. 
Sources indicate that this visa will 
in all likelihood not be offered in 
the near-future. 
Postgraduate Training 
Following last year's CIMS match 
surprise in which 96 Canadian 
graduates were left unmatched 
(double that of the previous year), 
postgraduate deans and program 
directors were left scrambling to 
avoid repeating this disastrous 
outcome once-more. At this point, 
the National Coordinating 
Committee on Postgraduate 
Medical Training is maintaining its 
recommendation that all Canadian 
medical graduates be guaranteed 
postgraduate training . Unfor-
tunately, some Provincial Deputy 
Ministers of Health have indicated 
that they may not be able to fund 
sufficient entry level positions to 
cover the size of the graduating 
class . Plans to restrict access of 
International Medical Graduates to 
postgraduate training have been 
discussed as have plans to ensure 
that students funded through the 
Department of National Defense do 
16 
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not take up spaces fu nd ed by the 
Ministry of Health. The results of 
these initiatives is yet to be seen. 
On a more positive no te, CIMS 
has agreed to set up a PGYI /PGY2 
registry in which residents wishing 
to transfer to othe r training 
programs may enter a central 
registry which will help them trade 
programs with other residents. The 
process will remain confidential 
until a match is made at which time 
the program directors will be 
notified and given the choice of 
accepting or declini n g such an 
exchange. 
The provinces are currently 
investigating the use of training 
cards as a mechanism of funding 
postgraduate trainees. Tradi-
tionally, the Ministries of Health 
have allocated funding d irectly to 
postgraduate training positions. 
A a result, stu dents could only 
apply to positions which received 
government funding. Under the 
proposed changes, the funding 
would be directed towards the 
postgraduate trainee h imself/-
herself. Each graduate would then 
receive a training card which 
would guarantee the holder full 
funding for training for the 
duration of their program. This 
would red u ce the number of 
funded but vacant po itions (e.g. 
anatomical pathology) and make 
tracking of expenditures easier for 
the Ministries of Health. Other 
issues concerning training cards are 
currently being evaluated by the 
provinces. 
CFMS Annual Meeting 
Thirty-six delegates met on 
October 1-3 in St. John' , 
Newfoundland to participate in the 
13th Annual General Meeting of the 
Canadian Federation of Medical 
Students (CFMS). The CFMS 
represents over 5500 Canadian 
Medical Students attending all 13 
anglophone medical schools across 
the country . Reports were 
presented from all the participating 
schools as well as from the four 
regional directors . Discussions 
centered around postgraduate 
prelicensure training (acceleration 
of career decision making, access, 
portability, and MCCQE Pt II), 
Facu l ty News 
po tgraduate training in the U.S., 
and rural medicine among other 
issues . The CFMS continues to 
participate in many national forums 
which direct policy decision. 
References 
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This year, UWO sent three delegates 
to the CFMS-AGM: Lesley Horton -
Meds ' 94 (Ontario Director) , 
Ambrose Au - Meds '95 (Sr. Rep) , 
and Elin Ringstrom - Meds '96 (Jr. 
Rep). We will continue to represent 
UWO medical students to the 
Canadian and Ontario Federations 
by mean of regular meetings, 
information and feedback sessions, 
and active lobbying. Please do not 
he itate to contact any of us with 
your concerns or interests. 
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Senescence 
of the Clock: 
gating the Re l ations of 
Rhythmicity and Circadian 
ABSTRACT 
R ecent advances on th e decay of c ir c adian 
rhythmicity as part of 
th e mechanism of 
mammalian senescence 
are explored . Appro-
priate historical and 
sc ientif ic ba ckground 
information is provided 
along with concepts of 
experim enation and 
intervention . 
INTRODUCTION 
Humanity is a tool-making species, conditioned by 
the constant presence of machinery to accept that the 
eventual wear and decay of any mechanism is 
inevitable. In keeping with this, the aging of the body 
is compared to the wearing out of old machines and 
assumed to represent a similar process. In fact, the 
resemblance is only superficial. Aging in mammals is a 
pre-programmed stage of development brought about 
as purposefully as puberty and similarly determined 
by evolutionary forces. Two basic pieces of evidence 
support these ideas and run counter to aging 
hypotheses which postulate an inevitable accumulation 
of damage, genetic errors, or toxins: First, every species 
has a characteristic lifespan. Within phylum Chordata 
(the vertebrates) at least, lifespan is more precisely 
regulated in higher forms such as mammals, than in 
lower ones, such as fish. Second , the 
rectangularization of human survival curves with 
improved social conditions and medical care indicates 
that, although the average lifespan has increased over 
the past few centuries, the maximum spans achieved 
have not. In humans, death occurs no later than one 
hundred years or so after birth. ' 
ABOUT THE AUTHOR: 
Ross Mantle is a third year medical student at the University of Western 
Ontario. He received a BSc degree from the lAurentian university. This article 
is a condensed version of a Problem-based learning (PBL) honours project. 
The joumal encourages students to submit condensed versions of such 
projects for publication. 
by Ross Mantle , BSc, Meds '95. 
BIOLOGICAL TIMING 
Assuming aging is preprogrammed, 
be a means within each individual of "<='""" .. 
time with reasonable precision and initia the 
appropriate developmental changes. Such a biological 
"clock" would require, by analogy to mechanical 
clocks, an oscillator with a fixed frequency (the 
"pendulum"), a means of adding up the oscillations to 
mark off larger blocks of time, and a way of 
communicating or acting on this information (the 
"hands"). 
Circadian rhythms are daily cycles entrained to the 
rotation of the earth by certain cues, called zeitgebers 
(time givers) such as light, temperature and the tides. 
For most species, the most potent zeitgeber is light. In 
the absence of external stimuli, true circadian rhythms 
continue, but with a period that is usually slightly 
faster or slower than 24 hours. An oscillating 
mechanism consisting of a series of enzymatic protein 
conversions forming a cyclic cascade, has been 
proposed as a general model. Although little solid 
experimental evidence exists to support this idea, the 
pendulum of our internal clocks may have evolved 
from the synthetic response of the organism ' s 
enzymatic machinery to the daily pattern of stresses 
imposed on it by the environment. The accuracy of the 
period of a circadian rhythm running in the absence of 
environmental cues can be better than ±0.01 h/ cycle in 
single celled yeasts.2 
The means by which a biological clock might mark 
off the passage of days, months and years is the least 
understood component of biological timing. In order to 
explain four day estrous cycles, menstrual cycles and 
other timed occurences involving intervals which are 
much longer than one day, the "resonance hypothesis" 
18 
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po tulates a beat phenomenon between two oscillators 
operating at slightly different frequencies . Beats in the 
levels of neurohormones mar trigger developmental 
changes including senescence. 
THE MAMMALIAN HYPOTHALAMIC-
PINEAL AXIS 
THE PI EAL 
The pineal gland was named for its pine cone shape 
and resides in the brain . Phylogenetically, the pineal 
organ is known to have been a third, median eye in the 
foreheads of the dinosaurs and many primitive present 
day ve rtebrates. The closest living relative of the 
dinosaurs, the tuatara of New Zealand (Sphenodon 
punctatum), is a large lizard which still exhibits a well-
developed third eye in the middle of its forehead. The 
third eye may have a lens and retina, although the eye 
never approaches the image-forming capability of the 
4 
lateral eyes. The pineal organ, or epiphysis, is found in 
the brains of among the most primitive of vertebrates and 
the most advanced (with the possible exception of one 
mammal, the nine-banded armadillo).5 Over the course of 
evolution the pineal gland has been highly conserved. 
Pineal eye information keeps organisms in synch with 
their environment , communicating not only whether it is 
night or day, but also the season, most likely based on 
whether the days are lengthening or shortening. Such 
information is necessary for migration, seasonal changes 
in plumage or fur colour, food storage and hibernation 
behaviours, and breeding. 
Articles 
THE SUPRA CHIASMA TIC UCLEI (SC ) 
This portion of the brain is now considered the master 
circadian oscillator in birds and mammals. The SC is 
an oscillator which can function independently, but 
which is also entrained to the ambient photoperiod 
through its connection with the optic chiasm. Once the 
SC , entrained to external lighting, reaches the "night" 
portion of its cycle, nerve impulses are sent to the 
pineal, which responds with an increased activity in the 
rate limiting synthetic enzyme for melatonin, 
acetyltransferase. Melatonin is then secreted$ feeding 
back to the SCN in a classic loop arrangement.6. 
MELATO IN AND PINEAL SECRETIONS 
Mela~onin is synthesized almost exclusively in the 
pineal. In primitive vertebra tes, melatonin causes 
clustering of melanin pigment within melanocytes 
leading to an overall depigmentation of the skin. 
The first inkling of a broader range of function for the 
pineal came when Otto Heubner observed that tumours 
which destroyed the pineal in young children resulted 
in precocious puberty. High levels of melatonin have 
been found to suppre s gonadal development, such that 
rats kept in continuous light (so that nighttime pineal 
ecretion of melatonin is suppressed) have increased 
gonadal development, and nighttime melatonin levels 
• drop by 75% over the course of puberty. Melatonin is 
ecreted at night in both nocturnal and diurnal animals. 
The pineal is associated with psychiatric disease in 
humans, particularly affective, schizo-affective and 
schizophrenic disorders. Evidence of disturbances in 
circadia n rhythms in these patients has led to the 
speculation that the cau e of many of these problems is 
desynchronization, improper phase relationships or 
beat phenomena (especially in bipolar affective 
disorder) in internal timing mechanisms.5 Perhaps the 
most drama tic example of the psychiatric effects of 
pineal func tion involves the successful treatment of 
seasonal affective disorder with light. 10 
THE ANTI-AGING EFFECT OF MELATONIN 
A group of scientists in Switzerland recently made a 
discovery which may have very profound implications 
for the future practice of medicine. In the course of a 
three year experiment in which mice were given nightly 
doses of melatonin starting at 1.6 years of age, the 
melatonin group lived 20% longer on average than 
controls." 
Only two other experimental manipulations are 
known to sign ificantly increase lifespan in mammals: 
subsis tence level caloric r estriction a nd 
12 • • hypophysectomy. The former effect was ongmally 
observed in 1935 by McCay and colleagues and has 
since become a cornerstone of aging research with a 
large number of new discoveries being made each 
13 
year. Food restriction can retard aging to the extent 
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that lifespan is increased up to 30%. Hypophysectomy 
has been shown to have similar, though smaller (-11 %) 
We-prolonging effects with or without efforts to replace 
pituitary hormones. HypophY,sectomy may also be 
combined with food restriction.14•15 For a review of the 
effects of food restriction and the manipulation of 
endocrine glands on aging, see Everitt and Meites, 1989. 
THE MELATONIN EXPERIMENT 
A three year experiment was conducted in which ten 
black male mice were given drinking water containing 
0 .01 mg / ml melatonin. Both the ten mice in the 
experimental group and ten controls were allowed 
access to drinking water only at night, from 6 pm to 
8:30 am. The mice were kept in cages with burrows in 
which the mice could sleep during the day. A constant 
12:12h light-dark cycle was maintained at a temperature 
of 23°C. The average lifespan was 2.06±0.22 years 
(752±81 d) in the controls, and 2.62±0.22 years (931±80 
d) in the melatonin group. This represents an increase 
in lifespan of about 20%, significant to p<O.Ol. 
At least two methodological criticisms of this work 
can be raised . One involves the use of syngeneic mice 
(strain C57BL / 6J). As is well known, highly inbred 
s train s of lab mice may have precisely determined 
lifespans due to the consistent development of a fatal 
lesion such as a brain tumour at a certain age. The 
administration of a drug which is effective against that 
specific ailment may prolong life without retarding the 
actual aging process . The Swiss experimenters, 
however, believe that melatonin acts on aging itself 
chiefly becau e of the youthful appearance, activity 
pattern and body weight of the mice on mela tonin . 
Another possible source of error in interpretation in the 
melatonin experiment is the con tant 12:12 h light-dark 
cycle . Mice are seasonal breeders with a four day 
estrou cycle. Since all the subjects were male, estrous 
cycling would not be expected to play a role. However, 
the lack of seasonality may have had an effect on the 
outcome of the experiment. 
These results have since been replicated with other 
syngeneic s trains and using females. Starting mela tonin 
at one yea r rather than 1.6 years actually shortened 
survival in C3H / He female mice by inducing ovarian 
cancer, although longevity enhancement was r tained 
when the melatonin was started at a later age. 16 Similar 
trial involving both males and females in natural 
(seasonal) lighting would be interesting. 
POSSIBLE MECHANISMS FOR THE ANTI-AGING 
EFFECT OF MELA TO I 
Arm trong and Redman theorize that melatonin acts 
as a nightly synchronization signal which entrains all of 
the daily rhy thms in the body o that they may act in 
concert. A decrease in the amplitude of the melatonin 
signal with age might therefore result in progressive 
desynchronization of the body's rhythm and 
consequent loss of function in all systems, leading 
17 
eventually to death. According to their interpretation 
of the melatonin experiments, exogenous, nightly 
melatonin strengthened the natural nightly level so that 
internal synchronization could be maintained for a 
longer time. This "progressive desynchronization" 
theory of aging is not new, and was probably first 
elucidated by Aschoff in the nineteen sixties in the US. 18 
Several current papers document the decrease in the 
. • • 19· 21 . 
mghtly melatonm pulse m humans. Nightly 
melatonin peaks decrease in a fashion that is roughly 
exponential with increasing age.22 
EFFECTS OF PINEALECTOMY 
Pinealectomy has been shown to produce a syndrome 
similar to that seen in aging, including a rise in 
cholesterol, triglycerides and circulating phospholipids 
(Pierpaoli et al, 1991), hypertension, loss of electrolyte 
balance, diabetes-like symptoms, dissociation of rapid 
eye movement sleep from slow-wave sleep, elevation in 
alkaline phosphatase, increased formation of abdominal 
fibrous tissue (adhesions), increased skin pigmentation, 
and reduced formation of prostaglandin E1 and 
thromboxane A. Many of these symptoms can be 
countered by administration of exogenous melatonin at 
the appropriate time (early subjective evening).17 
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RA DOMIZED CLINICAL TRIAL OF MELATONIN 
HUMA S 
23 The very low toxicity of melatonin and the fact that 
it has been used to good effect in clinical trials on sleep, 
d l 10,24 h . h h p ychiatric disorders an jet ag toget er w1t t e 
evidence concerning its effect on the longevity of mice 
sugges t that the time may be appropriate for clinical 
trials on humans. A medium scale randomized clinical 
trial involving a modest dose of melatonin at night only 
( orne authors s ugges t 2.5 m g/ d) 17 and enlisting 
subjects in la ter life, perhaps starting at age 65, would 
provide invaluable opportunities to s tudy the effect of 
the substance on sleep patterns, d epression, infection, 
hy pertension, blood cholesterol, tumorigenesis and , 
over an extended period, longevity. 
I would like to thank Drs. Flummerfelt and Walker for 
their practical advice. 
REFERENCES 
1. Comfort A 1988 The Biology of Senescence Elsevier. New York 
2. Morse OS, Fritz L, Hastings JW 1990 What is the clock? Translational 
regulation of circadian bioluminescence. TIBS 15:262-265 
3. Lehrer S 1983 Puberty and resonance: a hypothesis. Tire Mount Sinai 
journal of Medicine 50(1):39-434. 
4. Weichert CK 1970 Anatomy of the Chordates. McGraw-Hill, Toronto, 
p.622 
5. Annstrong SM 1989 Melatonin : The internal zeitgeber of mammals? 
IV.D. Clinical considerations. Pineal Research Reviews 7:157-202 
6. McArthur Aj, Gilette MU, Prosser RA 1991 Melatonin directly resets 
tire rat suprachiasmatic circadian clock in vitro. Brain Research 
565:158-161 
7. 11/nerova H, Vanecek J Effect of light on the N-ilcetyltransferase rhythm 
in the rat pineal gland. Advances in pineal research 1:69-76 
AND NOW 
~GES"­
OFTOMORROW 
/_-f'ftJt:JivA (}ulv~~ 
~ 
FI~~Health 
,._eo._.- Llonite4l 
1151 5.Jnctslane UM:Jr POtnriQ Olano t rw JR!J 
~~·~1]11444 
Delsym • Corsym • Caldesene 
Clearblue • Clearblue EASY 
Clearplan • Desenex • Cruex 
Articles 
8. Pang SF 1985 Melatonin concentrations in blood and pineal gland. 
Pineal Research Reviews 3:115-159 
9. Kolata G 1984 Puberty mystery solved. Science 223:272 
10. Arendt j 1985 Mammalian pineal rhythms. V Pathological melatonin 
rhythms. Pineal Research Reviews 3:161-213 
11 . Pierpaoli W, Maestroni Gj 1987 Melatonin: a principal 
neuroimmunoregulatory and anti-stress hormone: its anti-ilging effects. 
Immunology Letters 16:355-362 
12. Everitt A, Meites j 1989 Minireview: Aging and anti-aging effects of 
lronnones. jounrnls of Gerontology: Biological Sciences 44(6):B139-147 
13. Yu BP 1990 Food restriction research: Past and present status. Review of 
Biological Research in Aging 4:349-371 
14. Everi tt AV 1988 Hormonal basis of aging : antiaging action of 
hypophysectomy. in Regulation of Neuroendocrine Aging (Everitt and 
Walton eds) S. Karger, Basel pp. 51-60 
15. Masoro Ej 1988 Minireview: Food restriction in rodents: An evaluation 
of its role in the study of aging. journals of Gerontology: Biological 
Sciences 43:B59-B64 
16. Pierpaoli W, Dal/'ara A, Pedrinis E, Regelson W 1991 Tire Pineal Control 
of Aging. Tire effects of melatonin and pineal grafting on the survival of 
older mice. Amrnls of tire New York Academy of Sciences 621 :291-313 
17. Annstrong SM, Redman JR 1991 Melatonin: A clrronobiotic with anti-
aging properties? Medical Hypotheses 34:300309 
18. Richardson GS 1990 Circadian rhythms and aging. in Handbook of the 
Biology of Aging (3rd) Academic Press, Toronto, pp. 275-305 
19. Iguchi H, Kato K, lbayashi H 1982 Age-dependent reduction in serum 
melatonin concentrations in healthy human subjects . J Clinical 
Endocrinology and Metabolism 55(1):27-29 
20. Waldhauser F, Dietzel M 1988 Daily and annual rhythms in human 
melatonin secretion: role i11 puberty control. Annals of tire New York 
Academy of Sciences 453:205-214 
21. Shan11a M , Palacios-Bois J, Schwartz G, Iskandar H, Thakur M , Quirion 
R, Nair NPV 1989 Circadian Rhythms of melatonin and cortisol in 
aging. Biological Psychiatry 25:305-319/ 
22. Waldlrauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M , 
Sclremper M , Frisch H 1988 journal of Clinical Endocrinology and 
Metabolism 66(3):648-652 
23. Lerner AB, Nordlund Jl 1978 Me/atoni11 : Clinical pharmacology. j 
Neural Transm 13(suppl):339-347 
24. Petrie K, Conaglen JV , Thompson L, Chamberlain K 1989 Effect of 
melatoni11 on jet lag after long /raul flights. BMJ 298:705-707 
~MDS 
__ •su __ Lab_o_m_to_n_·e_s _____ _ 
MDS Laboratories extends 
a sincere Best Wishes to the 
Medical Students at the 
University of Western Ontario. 
Wishing you a bright future. 
MDS Laboratories is a division 
of MDS Health Group Limited 
U. W .O. Medical Journal 63 (1) 1993------------------------ 21 
Articles 
AN INTERVIEW WITH DR. LeRICHE 
INTRODUCTION 
D r. Nicole LeRiche began her 16-year association with the UWO Faculty of Medicine in 1977 as an intern. After obtaining her FRCPC in Internal M edicine, she 
engaged in clinical studies in rheumatology at the National 
Institute of Health (NIH) in Maryland from 1982-84. Since 
her return to London in 1985, she has served on numerous 
committees, published severa l papers, and taught both 
undergraduates and graduates. She and her husband, Dr. 
John H owa rd , have also found the time to raise three 
children. Dr. LeRiche was appointed as "Deputy Dean" in 
the Spring of 1993; this title has since been changed to 
Associate Dean of Academic and External Affairs. 
RHEUMATOLOGY 
Why did you choose to subspecialize in 
rheumatology? 
"I like internal medicine, and I think rheumatology 
really spans a lot of internal medicine as an intellectual 
discipline ... There's a need for rheumatologists. There 
are so many people who could benefit from seeing a 
rheumatologist there's usually an oversupply of 
patients. 
Knowing that I wanted to be able to control my 
hours to a greater extent than I would be able to if I 
were doing general internal medicine was a prime 
consideration, because at that time I knew that my 
husband and I would want to have children and I knew 
that my husband was also doing internal medicine. That 
was one way we could negotiate that difficulty of 
having enough time for ourselves, our family and so on. 
It was a combination of things that helped me make the 
decision." 
BEING AN ASSOCIATE DEAN 
How did you become an Associate Dean? 
"You really have to ask Dr. McMurtry as to how I 
came here- Dr. McMurtry is the one who asked me 
whether I would do what I am doing. I think some of it 
occurred as a result of the fact that I was invited to be 
part of the Strategic Planning Exercise which went on 
last year. Last year, because of the fact tha t Dr. 
McMurtry had recently arrived on site, he wanted to a 
have a good idea about a number of issues within the 
faculty. 
Early in January, when he was making selections for 
Assistant and Associate Deans, he asked me if I would 
be interested in the post of " Deputy Dean". My first 
reaction was one of amazement, but the more I thought 
by Susan Huh, Meds '97 
about it the more interesting it sounded. Certainly, it 
was nothing I necessarily would ha ve applied for 
myself. 
Bioniche 
A new emerging Biopharmaceutical 
company requires a research nurse to be 
part of its clinical research team. 
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• Nurse (BSc preferred) 
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• Required to travel within Canada 
• Bilingual (preferred) 
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Send resume to: 
Dr. Ingrid Van der Linden 
Bioniche Inc. 
27-69 Bessemer Rd. 
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What is the role of an associate dean? 
"My role as I see it is to do a number of different 
thing . I have responsibility for so-called clinical affairs, 
which is looking after the Faculty Practice Plan; this 
plan involves how faculty are paid. In addition, I may 
stand in for the Dean if he's absent. I'm on a number of 
task forces which have been struck within the faculty as 
a re ult of the Strategic Planning Exercise. I think by 
being on a number of task forces, I have a fair idea of 
what's happening in all of them, so there will be a 
minimum of duplication in other task forces . 
I think what Dr. McMurtry had originally intended 
was that the "Deputy Dean" act as a "backup" - to 
stand in for him as needed. The official title of As ociate 
Dean of Academic and External Affairs merely reflects 
the breadth of things that he'd like me to be involved 
with, and that I'd like to be involved with." 
What kind of an impact will your position have on 
faculty and students? 
"The kind of impact that I'll have is more easily seen 
with faculty. By extrapolation, if faculty feel better 
about things in general then students will feel better 
about things in general. 
I think what we're trying to do is make changes 
which will better reflect what people do, how they' re 
rewarded, and how we carry on day-to-day operations 
withi n the faculty. As an example, there's a 
com munications task force ... trying to look at 
communications in general across the faculty. I like to 
think of that as not only the cut-and-dry memo-sending 
that goes on, but in fact how we talk to one another. Is 
there a sense of belonging, and cohesion, a sense of 
esprit-de-corps within the faculty itself? ... I think that if 
we can find ways of recognizing people in meaningful 
ways so that they feel that they' re part of the faculty, 
that feeling will grow ... 
Bear in mind the difficulty at times in how to get 
va riou parts of the faculty talking to one another on 
everal levels: "talking" in the ense of doing research 
with one another, how to teach most effectively, how to 
do the best patient care you can, that kind of thing ... I 
see my role perhaps as a facilitator of those processes; I 
have no illusion that one person can do it, but if there 
are a number of people whose aim it is to improve a 
number of those things, it's more likely to happen." 
Do you still find time to practice? 
"I had a very full clinical practice before I started this 
position, and still do . [laughter] It's a little bit of a 
challenge to try to fit everything in. I still feel a great 
responsibility to continue to see patients, but I have had 
to cut back a little bit, because of the fact that I'm doing 
a lot more with the Faculty. It's funny, I was reflecting 
on that a few weeks ago ... I think it gives me a 
perspective that is really critical, that I'm still doing the 
Littmann™ 
Master 
Cardiology 
stethoscope 
coustical excellence, 
ovative design, 
tched performance 
Articles 
U. W .O. Medical Journal 63 (1)1993------------------------ 23 
Articles 
day-to-day stuff that many of my colleagues a re also 
doing ... I think it's very important not to become 
divorced from what our primary goals are, which I see 
as teaching medical s tudents, doing research, and 
seeing patients. All those things are very important." 
STRENGTHS OF UWO MEDICAL SCHOOL 
" I think one of the things that I found really 
refreshing when I came here, was the fact that people 
seemed to be very approachable. I think and I hope that 
s tudents feel that. At times I worry that the re are 
perhaps unnecessa ry barriers that exist, studen ts 
presume things about consultants and vice versa. But I 
think on the whole there ' a reasonably cordial 
atmosphere here. 
I think that the quality of teaching is good. I'm 
concerned, and thi s is being addressed in the 
curriculum, about overstuffing people with facts. But I 
think that certainly the kinds of trainees with whom I 
work are excellent. They ' re well-trained, they're 
knowledgeable, they're kind people, they're the kind of 
doctors that I would want to go to. I think on the whole, 
that whether it's the admissions policy or just the 
institutional ethos in general the people are delightful." 
PROBLEM-BASED LEARNING 
Why is the school moing toward a more completely 
problem-based learning curriculum, considering the 
success rate of Western's graduates? 
"I think there is a recognition on the part of not only 
physicians practicing within the system, but the public 
as well , that phys icians who have very good 
communica tion skills, and who are empathic would be 
preferred . I think this is more easily taught within the 
context of a small group, and examining a variety of 
different problems from a number of different angles." 
WOMEN IN ACADEMIC MEDICINE 
"Young women may be starting to select themselves out 
of doing sc ience and things like that w hi ch are 
prerequisites for medicine ultimately, because there's 
sort of a societal view that this isn't really women's 
work. I think that's happening less and less. 
There ma y not now be the active discrimination 
which existed before, but unfortunately there may well 
be barriers ... 
There are some things within the system which do 
make it harder for women to either become part of the 
system, or to succeed in the system. I think that we're 
trying to make changes that will make tha t ... easier. 
Certainly Dr. McMurtry is, I think, very aware of that 
difficulty." 
Why hasn't the increase in female enrollment in 
medical school been accompanied by an equivalent 
increase in all specialties of medicine? 
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"A lot of reasons. A lot of it is self-
selection . . . women want flexibility , and 
certainly my friends doing family p ractice 
probably have greater flexibi lity. If they want 
to have children, they can take that time off to 
be home with thei r child much more easily. 
The more one s ubs pecializes, the more 
difficult that beco mes because it's more 
difficult to replace yo u in a particular 
situation." 
THE STATE OF CANADIAN 
HEALTH CARE 
"I think tha t many people didn't realize that 
there has beens a nd is a finite quantity of 
resources. Unfortunate ly w ha t happened i 
that people were pending as if there weres 
no tomorrow ... 
Things eem a lot bleaker when one ha 
been raised in an environment of incredible 
plenty which then become re tricted. I think 
that this is the i s u e w hi ch we are a ll 
grappling with. The feelings of frustration are 
und ers tandable because we have come to 
enjoy a very good sta nda rd of living on the 
w hole ... 
If we as a profession recognize wha t our 
goa ls are, and w h e re we want to s p end 
money and how we wan t to spend ou r time, 
we can still do what we want to do ... we must 
all be accountable for our pending ... ' we' re 
all part of the ystem, and we all have 
responsibilities to try and make the best u es 
of the resources that we have' ... 
I'm concerned by the fact that things have 
become so provincial, because I see myself a 
a Canadian, I don't see myself as only an 
Ontarian ... Everything else is becoming more 
global- why are we becoming more 
perochial? But it' an understandable reaction 
because everybody feels threatened ." 
PERSONAL GOALS 
"I like to think of life as a series of adventures 
and that variou things occur and you're 
lucky enough to meet interesting people ... I 
suppose that a major goal is in trying to be 
the best physician that I can be, to learn as 
much as I can, and as well to try to convey 
tha t desire to other people ... perhaps we have 
to be more in touch wi th and allow our elves 
time to think about tho e important things 
which make up life. In a peculia r way, we as 
physicians are o intensely involved in other 
people's lives that we forget the big picture 
and don' t think about how amazing life is." 
n 
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NEUROLOGIC SEQUELAE OF 
HUMAN 
VIRUS-1 
IMMUNODEFICIENCY 
(HIV-1) INFECTION 
by Jeffrey M. Politsky, MSc, Meds '94, 
David M Pelz, MD, FRCP(C), Meds '75, & Thomas W. Austin, MD, FRCP(C), Meds '65 
ABSTRACT 
H uman Immunodeficiency virus-1 infection is a commonly occurring and an incompletely understood illness which can have severe effects on the central 
nervous system. Theories of disease transmission relate to 
immune-mediated transfer, endothelial cell infection, and cell-
spec ific susceptibility . Neuro-
pathologic alterations include diffuse 
and focal brain changes, and may 
occur secondan; to enhanced cellular 
immunity, increased secretion of viral 
proteins, and /o r excitotoxic 
mechanisms of cell damage. Central 
neurologic findings include the AIDS 
dementia complex and acute and 
subacute focal brain disea ses. 
Recognition of the neurologic signs 
and symptoms of human 
immunodeficiency-1 virus infection 
clinically and through the use of 
neuroimaging techniques is critical 
for effective therapy. Despite 
therapeutic intervention, prognosis of 
human immunodeficiency virus 
infected patients remains guarded. 
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INTRODUCTION 
Systemic human immunodeficiency virus-1 (HIV-1) 
infection is a common ye t incompletely under tood 
illness. This illness, specifically the late phase of 
acqui red immunodeficiency syndrome (AI DS), is 
complicated by direct central nervous system (C S) 
infection and by neurologic disease 
from the onset of the initial illness. 
eurologic sequelae of HIV-1 
infection relate to the acquisition of 
opportunistic infections and the 
development of C S neoplasms. 
Early recognition of the neurologic 
signs and symptoms has 
implications for both diagnosis and 
management of HIV infection and 
AIDS. Further, diagnosis and 
management can provide clue to 
the underlying mechanisms of HIV-
1 infection. This paper provides an 
overview of the neurologic 
complications of HIV infection, 
including theories of transmission 
and neuro-pathology. As well, the 
clinical neurologic findings of HIV infection are outlined 
- recognition of these signs and symptoms has 
diagnositic and therapeutic significance. 
TRANSMISSION 
The exact mechanism of transmission of HIV -1 and 
HIV-1-related secondary infections into the C S is 
currently unknown. Possible mechanisms of transmission 
are based on findings that hematogenic and/or neuroglial 
cells may be preferential tar&~ts for HIV -1 and HIV -1-
related secondary infections. One theory is immune-
mediated transfer of vira l particles .' For example, 
although microglial cel ls are the primary target of 
retroviral infection, these cells lack CD4 receptor sites (the 
HIV-1 cell surface receptor protein). These cell do, 
however, have high affinity receptors for 
imrnunogloblulin, making antibody-mediated uptake into 
brain tissue a possible mechanism of infection. ' Other 
studies also implicate neuroglial and hematogenous cells 
as bein&} nvolved in the transmissability of virus 
particles. This involvement is based on the observation 
of budding of HIV-1 particles from cell membranes of 
multinucleated giant cells (macrophages) and monocytes 
predominantly, although neuroglial cells are also 
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involved.u These findings suggest ingestion, djgestion, 
and replication of HIV-1 by brain macrophages. 
Another theory suggests endothelial cell infection as 
• the primary mechanism. For example, immunohisto-
chemical localization of CD4 and HIV-1 antigens to 
cerebral and lymphatic venular endothelial cells 
supposes either natural occurrence or induction of CD4 
protein in various endothelial cells, thus allowing HIV-1 
to be transmitted from circulating infected leukocytes to 
4 
targeted tissues. This study also suggests that the high 
HIV-1 immunoreactivity of macrophages and 
multinucleated cells in post-mortem tissue may be due 
to immune-mediated sequestration of HIV-1 antigens 
from initially infected hematogenous cells.' 
Neuroglial cells also appear to be sensitive to HIV-1-
related secondary infections. For e.g., one 37 year old 
HIV-1-positive man with a history of pneumocys tis-
cannu pneumonia died of disseminated 
cytomegalovirus (CMV) infection and an anaplastic 
astrocytoma.5 CMV-bearing astrocytic cells were found 
throughout the tumour, but not elsewhere. As well, 
CMV-bearing endothelial cells were noted in several 
capillaries within the tumour. Microglial nodules and 
multinucleated giant cells (MGCs) were also found in 
the tumour and also stained posi tive for CMV. These 
authors concluded that astrocytoma cells are permissive 
to CMV, that these cells are more susceptible to CMV 
infection and replication than normal tissue, and that the 
entry of CMV may be due to alterations in the 
astrocytoma blood brain _barrier (BBB) and the 
hyperplastic endothelial cells., These factors may play a 
role in the development of opportunistic infection in the 
presence of other C S neoplasms. 
NEUROPATHOLOGY 
europatholgic studies carried out on post-mortem 
brain tissue from HIV-1-positive induviduals are critical 
in furthering our unders tanding of the neurologic 
sequelae of HIV -1 infection and AIDS. These studies 
have revealed that specific areas of the brain are 
preferentially affected in HIV-1 infection. As well, HIV-1 
and HIV-1-related secondary infections have a 
predilection for certain neuronal cell types. The 
development of HIV-1-related secondary infections 
represents an important aspect of neurologic disease in 
AIDS. Clinically, these opportunistic infections may lead 
to the development of AIDS dementia complex (ADC). 
Pathologically, these infections signal the terminal s tage 
of AIDS. Although some explanations are forthcoming, 
the mechanisms underlying these various pathologic 
changes remain unclear. 
europathologic alterations occurring in AIDS are 
6, 10-12 
associated with the cerebral hemispheres, basal 
ganglia·""9 brain s tem structures and spinal cord,24 inferior 
1. 1 . 13 1 6 d h 14.32·36 o 1vary nuc e1, corticospina tracts, an t e eye. 
Primary histopathologic findings in brain tissue from 
AIDS patients can be divided into diffuse and foca l 
changes. Diffuse changes include cortical atrophy, white 
matter pallor, vascular calcification, multinucleated cell 
encephalopathies, and vacuolar myelopathy.5'8 '9' 14• 16' 18•22 
Focal changes include the acquisition of various 
opportunistic infections, encephalitides, malignant 
neoplasms, and pro~nessive multifocal 
1 uk hal h (PMLE) '81.13,15- 17.19-22 e oencep opa t y . 
DIFFUSE CHANGES 
Cortical atrophy is the most consistent finding in the 
cerebral ~~flli~here~ of AIDS patients with neurologic 
sequelae. Cortical changes are characterized by 
significant neuronal loss in the frontal cortex" and other 
f . 10,23 1 II oc1, a ong with decreases in neuronal density, 
perkiaryon volume fractions," and widened sulci. 25 A less 
common finding is cerebral spongioform changes of the 
white matter, characterized by small rounded 
vacuoles .23'25' 31 A more diffuse sponginess, status 
s pongiosis, charac terized by looser and coarser 
microcvstic cavitations has been observed in the gray 
matter. 
tl,25.31 
Subcortical structures are commonly involved in 
AIDS patients with neurologic complications. The most 
common histologic finding is diffuse white matter pallor 
with astrocytic reaction. Also common is dystrophic 
calcification of blood vessels in the basal ganglia.""9 The 
observation of MGCs is an indicator of more severe 
neurologic disease. Changes in these brains are found 
mostly in the deep gray structures and white matter and 
include gliosis, perivascular and parenchymal foamy 
macrophages, formation of microglial nodules, MGCs, 
and lymphocytes.9•15•18.25-28 Multinucleated cell encephalitis 
is also called HIV encephalitis because of the correlation 
between the presence of MGCs and opportunistic 
infections. (see figure 1) 
The most common pathologic finding in the spinal 
cord of HIV-1 infected patients with clinical neurologic 
symptoms is vacuolar myelopathy. 12•13•25•29.JO Clinically, 
vacuolar myelopathy is similar to subacute combined 
degeneration secondary to vitamin B12 deficiency; 
pathologically, the two entities are distinct since in the 
30 former, serum 812 levels are normal. 
Figure 1 
Axial proton density and T2 weighted images in a 40 year old male with 
AIDS. Diffuse deep white matter high signal in both cerebral hemispheres 
(a"ows) was pathologically proven to represent HlV encephalitis. 
28 
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Ophthalmic changes include ocular motor nerve 
pals ies, papilledema, CMV optic neuritis, cortical 
blindness, conjugate gaze palsies, and altitudinal visual 
field defects.' Retinal microvascular abnormalities in 
HIV-1 infected patients can also occur-in fact, ocular 
microan:@ iopathic syndrom e is common in these 
patients. - The major retinal microvascular alterations 
a re cotton-wool spots;33 other changes include retinal 
h e morhages, ectasia of conjunctival vessels, and 
conjunctival blood-flow sludging. 34•36 The e retinal 
change can be remarkably similar to those in diabetes 
mellitus and systemic lupus erythematosis.32 
FOCAL CHANGES 
Major focal pathologic changes in the brains of AIDS 
patients include opportunistic infections and neoplasms. 
The most important pathologic processes are cerebral 
to xoplasmosis, PMLE, and primary C S 
1 h 
9,15, 16,JS.:20.22.25 ymp oma. 
Figure 2 
Axia l T2 weighted M R 
image of the brain in a 33 
y ear old fema le w ith 
A ID S . Th ere is a large 
irregu lar high signal mass 
les ion in the deep right 
temporal lobe and there is 
a s maller nodu lar hig h 
s ig nal mass in t he left 
f rontal lobe. Th ese both 
represent ma nifes tations 
of cerebral toxoplasmosis. 
Cerebral toxoplasma (see figure 2) lesions are 
multifocal and ~ve a predilection for the ba a! ganglia 
a nd the cortex . Papovavirus, or PMLE, tends to be 
localized to the white matter and is associated with an 
a bsence of inflammatory infiltrates (see figure 3). 19 
Primary C S lymphoma may also have multiple foci 
and i usually identified in the white matter.25 (see Fig 4) 
Figure 3 
Axial proton density and T2 weighted MR images in a 62 year old female. 
Irregular high signal changes are seen in the periventricular white matter 
adjacent to tl1e atrium of the (arrows) left lateral ventricle and also in the 
posterior limb of the right internal capsule. These were pathologically proven 
to represent PMLE. 
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Currently, there is no decisive explanation for the 
neuropathologic changes in AIDS. One theory suggests a 
• hypersensitivity reaction. The interaction between the 
CD4 antigen (Ag) and Ag-presenting cells lead to 
enhanced cellular immune activity. The interaction of 
immune related Ag's on CNS vascular endothelial cells 
lead s to a breach of the BBB a nd could lead to the 
a cqui ition of opportunistic infections and HIV 
• vasculitis. Another possibility is that AIDS-associated 
neurologic disease is correlated with higher levels of 
HIV -1 Ag in tissues, which ultimately leads to increase 
secre tion of viral proteins or viral induction of 
cytokines. These substances then bind to glial cells and 
neurons stimulating a positive feedback loop (with 
further secretion of viral proteins and/or cytokines) .28 
Finally, an excitotoxic mechanism of damage has been 
proposed.37.38 In this theory, the final common pathway 
of damage may involve voltage-dependent calcium 
channels and NMDA receptor-operated channels, in 
mu ch the same wa;r_ a s damage occurs in stroke, 
seizure , and trauma . .38 
CLINICAL PRESENTATION 
The clinical pre entation of HIV-1 infection has been 
subdivided into four distinct phases (see table 1).39 The 
development of neurologic signs and symptoms in AIDS 
i u ually associated with phase IV illness, but distinct 
symptomatology such as ocular and psychiatric findings 
ma y occur at earlier stages . Nonetheless, the 
presentation of neurologic sequelae is an indication of 
advanced disease. 
Clinically, neurologic findings of AIDS fall under 
va rious categorie . Some of theses categorie include 
ocular, psychogenic, myelopathic, and central findings . 
The bulk of this discussion concerns the central 
neurologic finding , which can be subdivided further 
into diffuse (AIDS dementia complex) and focal brain 
disease. 
Figure 4 
Axial proton density M R image in a 41 year old male with A IDS. Irregular 
periventricular high sig na l les ions (arrows ) are seen bilatera lly which 
represent primary CNS lymphoma. 
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TABLE 1 
CLINICAL STAGING OF HIV-1 INFECTION39 
CENTRAL NEUROLOGIC FINDINGS 
Stage 
II 
ill 
IV a) 
b) 
c) 
d) 
e) 
Clinical Findings 
Acute HIV Infection 
As toma tic Carriers 
Persistent Generalized L 
Constitutional Disease 
Neurological Disease 
i} HIV-related 
ii) Opportunistic Infections & Neoplasms 
Secondary Infectious Disease 
Secondary eoplasms 
Other Conditions 
OCULAR FINDINGS 
Ocular changes and ophthalmoscopically visible 
changes have been observed in AIDS patients with 
clinical stage III and IV disease.24.34.36 The most common 
occular finding appears to be limitation of central eye 
24 
movement. Less common, but occuring equally 
frequently are peripheral eye movement limitations, 
abnormaliti~r of vision, and abnormal spontaneous eye 
movements. 
PSYCHOGENIC FINDINGS 
Diffuse Brain Disease 
(AIDS Dementia Complex) 
Although a certain percentage of diffuse brain 
disease relates to metabolic encephalopathies 
occurring secondary to systemic disease such as 
pneumonias with hypoxia and generalized sepsis, 
the commonest CNS complication of HIV infection 
is a constellation of neurologic sign s and 
symptoms referred to as the AIDS Dementia 
Complex (ADC).25 
AIDS dementia complex usually manifest itself 
after patients acquire AIDS-defining sys temic 
illnesses such as opportunistic infections or 
neoplasms (see table 2). The complex can occur, 
however, in the absence of these major systemic illne ses 
and is thus a separate entity among diagnostic criteria of 
AIDS.o . . 
Early symptoms relate to cognitive deficits, such as 
difficulty concentrating, impaired memory, and inability 
t f 1 k 19.25.26.42 .o per orm comp ex ta s s . In ea rlier stages of 
Illness, formal mental status testing ma y be quite 
normal. With increasing severi ty, howeve r, results 
become abnormal and include apathy, poor insight, 
impaired recognition , recall , attenti on and 
calculation. 1925.26•42 ' 
Gross and fine motor dysfunction become evident 
with the appearance of gait disturbances, poor balance, 
TABLE 2 
Psychologic disturbances appear to 
be re lated in part to the patient's 
awareness of being HIV-1-positive. 
These changes include depression1 
anxiety, and adjustment reactions .'o.• 
The asymptomatic s tage of HIV 
infection is not associated with 
significant cognitive impairment. 41 
Cognitive disturbances, which are 
associated with clinical neurologic 
symptoms and which may be revealed 
by neuropsychologic testing include 
difficulty with complex sequencing, 
impaired fine and rapid motor 
movement, and s lowed verbal 
DIFFUSE BRAIN DISEASE COMPLICATING 
HIV INFECTION25 
Level of Consciousness Complicating Disease 
Depre sed 
Preserved 
fl 19.25,42 uency. 
MYELOPATHIC FINDINGS 
Transverse myelopathies are rare, but can occur 
secondary to
25
spinal lymphoma and infection with 
herpes zoster. Polyradiculopathy secondary to CMV or 
combined CMV and herges simplex virus infections also 
occur and can be severe. The most common spinal cord 
finding is progressive vacuolar myelopathy. These 
patients present with gait disturbance, ataxia, and 
spasticity. Bladder and bowel dysfunction also occur as 
25 
myelopathy progresses. 
Metabolic Encephalopathies 
Toxoplasmosis ("encephalitic" form) 
Cytomegalovirus Encephalitis 
Herpes Simplex Encephalitis 
Acute HIV-1 Encephalitis 
AIDS Dementia Complex 
and eye and hand incoordination resulting in patients 
tripping, falling down, dropping items~ and finding 
themselves unable to eat or wri te. 19• 5'2 ... 2' 45 Motor 
dysfunction can sometimes be detected early on by 
recognition of abnormal or pathologic reflexes such as 
glabellar, snout, and grasp res ponses, as well as 
generalized hyperreflexia. Also, disruption and slowing 
of rapid sequential and alternating tasks involving 
fingers, wrists, and feet occur. Other early signs include 
ocular d ysmotility, disruptig n of smooth pursuit, and 
slowed saccadic movements. 
30 
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End stage presentations of ADC include bowel and 
bladder incontinence, a complete or nearly complete 
25 
vegetative tate, and marked reduction of arousal. 
One author has suggested that the "ADC" is really 
seronegative neurosyphilis : 6 This notion was 
formulated on the basis of five AIDS patients who were 
all diagno ed with ADC. Despite being seronegative for 
neu rosyphilis, the patients all showed a dramatic 
improvement in function and a marked reduction in 
impairment following either intravenous (iv) infusion of 
penicillin G or oral administration of doxycycline (the 
treatments for neurosyphilis) .46 Although neurosyphilis 
can' t be ruled out despite seronegativity, this reasoning 
i questionable on a few counts. First, only two of the 
five patients underwent investigations beyond simple 
serum and cerebrospinal fluid (CSF) studies. Further, 
these two patients received computed tomographic (CT) 
cans but neither magnetic resonance imaging (MRI) or 
brain biopsies. The latter two procedures are currently 
the most sensi tive diagnostic tools for the neurologic 
complications of HIV-1 infection. Thus, diagnostic 
attempts in these patients were incomplete. Second, the 
positive response to penicillin may have occurred 
because of another undiagnosed infection also sensitive 
to this therapy. Third, although the possibiltiy exists that 
the severe immunosuppression in HIV infection may 
render serologic tes ts for syphilis unreliable, substantial 
evidence is available to suggest that selologic tests for 
syphilis are indeed sufficiently reactive: 
Focal Brain Disease 
Apart from the diffuse brain processes discussed, a 
variety of focal brain disorders develop in AIDS 
patients. These focal disease processes may be acute or 
subacute in onset (see table 3), thus making clinical 
recognition important for appropriate therapeutic 
intervention . Acute processes are usually due to 
vascular events or seizures. Some vascular events such 
as trans ient ischemic a ttacks or s trokes may lead to 
permanent brain injury, but most have a benign course.48 
Onset 
Acute 
Subacute 
TABLE3 
Focal Brain Disease Complicating 
HIV Infection 25 
Complicating Disease 
Vascular Disorders 
Cerebral Toxoplasmosis 
Primary CNS Lymphoma 
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Most focal disorders are subacute in nature and 
evolve over days to weeks. Cerebral toxoplasmosis, 
primary C S lymphoma, and PMLE (papovavirus) are 
three of the most important focal disorders . These 
di order evolve rapidly over days, inter~ediat~X (days 
to weeks), and slowly over weeks, respectively. These 
di orders can produce overlapping, but often distinct 
neurologic symptoms. For example, cerebral 
toxoplasmosis usually produces a focal deficit along 
with a generalized encephalopathy leading to confusion 
or clouded consciousness.49.so PMLE, on the other hand, 
produces focal deficits without any effeft on 
consciousness until end stages of infection .5 CNS 
lymphoma can produce " frontal" or global mental 
dysfunction when the lymphoma is associated with a 
ignificant mass effect or is located deep in the frontal or 
periventricular region.
51 
DIAGNOSIS 
A number of investigative procedures exist which, 
when used in combination with clinical findings, may 
lead to correct diagnosis of C S complications of AIDS. 
Among these investigations, serum and CSF studies are 
the most specific,46~ whereas neuroim~g and brain 
biopsy studies are the most sensitive. Venipuncture 
and lumbar puncture, to obtain serum and CSF, 
respectively, are inexpensive and useful techniques to 
identify the presence of viral or bacterial-specific 
proteins, immune complexes, and altered cell counts.46~57 
For patients with neurologic symptoms who either 
require further localization of disease or whose CSF and 
serum results were non-specific, neuroimaging 
techniques and brain biopsy are often necessary. There 
appears to be some discrepancy as to which procedure is 
the most sensitive among CT scan, MRI, and brain 
biopsy. For e.g ., in 149 patients examined with 
toxoplasma abcesses, CNS lymphoma, and PMLE, MRI 
was found to be more sensitive than CT scan in 
detecting lesions, especially PMLE.58 CT scan was unable 
to distinguish mass lesions due to toxoplasmosis from 
those due to lymphoma .58 Other studies 
have also found MRI to more consistently 
reflect the histopathologically documented 
extent and distribution of CNS disease.8.su1 
Brain biopsy has also been used to achieve 
definitive diagnosis. For example, in one 
study s tereotactic brain b iop sy was 
performed after gadolinium-enhanced MRI 
or contrast-enhanced CT scan.63 After the 
biopsy material was examined cytologically, 
Progressive Multifocal Leukoencephalopathy 
Tuberculous Brain Abcess (M. tuberculosis) 
Cryptococcoma 
histologically, immunohistochemically, and 
by polymerase chain reaction, a definitive 
diagnosis was achieved in 92 % of the 
cases.
63 
In another study, definitive 
64 diagnosis was reached in 96% of cases. Varicella-Zoster Virus Encephalitis 
Herpes Simplex Encephalitis 
Subacute CNS Syndromes 
Brain biopsy is considered to be a safe 
effective means of diagnosis in this patient 
population.6U6 
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PROGNOSIS AND TREATMENT 
The effectiveness of treatment, and thus the 
prognosis, of AIDS patients with neurologic sequelae 
clearly depend on early and correct diagnosis and 
intervention. Even with these measures, the prognosis 
of HIV-1 infected and AIDS patients is bleak. The extent 
of neurologic involvement is also a key factor in patient 
outcome. For example, Mundinger et al. studied the 
survival of 41 AIDS patients with neurologic 
involvement based on neuroimaging re ults."7 The mean 
survival of patients with initially normal imaging 
results was 700 ± 89 days compared with 326 ± 65 days 
and 202 ± 97 days for patients with cerebral atrophy 
and focal lesions, respectively. The mean survival for 
patients with both cerebral atrophy and focal lesions 
67 
was only 78 ± 44 days. Further, these authors found 
that, compared with initially normal imaging, the risk 
of death increased 3.6 times with cerebral atroph , 6.4 
times with focal lesions, and 19.3 times with both. 
Medical therapy for neurologic complication of AIDS 
usually involves antimicrobial agent for opportunistic 
infections. To be effective, the e agents must cro s the 
BBB and the blood-CSF barrier. Currently, there are 
only a few such agents in use. Zidovudine is an anti-
retroviral thymidine analogue which has been shown to 
be effective in reversing ADC to a lesser stage in most 
seroP,ositive HIV pati e nts with mild end-stage 
A DC. !9.25.68 
In light of the possible overlap between ADC and 
neurosyphilis, a therapeutic trial of iv penicillin or oral 
doxycycline may be warranted for patients who ei ther 
don't respond to zidovudine, or who may in fact have 
neurosyphilis."" 
Cerebral toxopla s mo is is the most commonly 
occurring opportunistic infection to cau e encephali tis 
or multifocal brain lesion in AIDS patients. 25•69•70 
Although this parasi tic infection is associated with high 
morbidity and mortality, a good response to therapy 
and an imroProvement in patient survival has been 
shown. 25"'•· A therapeutic tri a l should be initiated in 
patients who show neurologic signs and symptoms and 
have th e characteristic lesions as evidenced by 
neuroimaging or biopsy techniques. The most effective 
anti-toxoplasma treatment currently available is the 
combination of pyrimethamine and ulfadiazine, which 
causes sequential blockade of folic acid metabolism in 
the para ite.25"'"·70 Therapy lasts for approximately three 
weeks, and may require the addition of folinic acid.69-71 
Pyrimethamine-clindamycin combinations have shown 
some efficacy in treating cerebral toxoplasmosis and 
69-71 
may be used in patients with a ulfa allergy. 
Like toxoplasmosis, C S lymphoma also produces 
neurologic symptoms secondary to rna lesions. nlike 
toxoplasmosis, however, few effective treatmen ts are 
available for CNS lymphoma- teroid may be able to 
reduce signs and symptoms eco
58
ndary to increased 
intracranial pressure, but little else. 
DISCUSSION 
Over the last ten years, HIV -1 infection has been 
shown to be a devastating illness with far-reaching 
effects on mankind . HIV-1 infection affects a number of 
organ systems, including the brain. This paper has 
provided an overview of the neurologic complications 
of AIDS. These complications are difficu lt to treat and 
to control. Progress is continually being made in 
understanding and managing these sequelae, but much 
work still remains . As a result of previous research, 
various theories explaining the causation of AIDS have 
been postulated. Of these theories, the possibility that 
neuronal damage in AIDS is mediated through 
excitatory amino acid activation and increased 
inracellular calcium appears promising. The 
combination of MDA receptor activation, enhanced 
inositol phospholipid metabolism, and toxic calcium 
influx leading to neuronal cell death may be involved in 
the pathogenesis of a variety of neurodegenerative 
diseases such as dementia of Alzheimer's type, 
olivopontocerebellar atrop~ cerebrovascular accident, 
and Huntington's disease; recently, this mechanism 
of cell damage has been extended to include th e 
ADC.37.38 Developing mechanisms to arrest excitotoxic 
cell damage are complex since they would involve both 
extracellular and intracellular proce ses. Expanding on 
this notion may lead to new therapeutic strategies for 
the trea tment of the neruologic sequelae of HIV-1 
infection and AIDS. 
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PYOGENIC HEPATIC ABSCESS 
INTRODUCTION 
A n hepatic abscess is a localized collection of pus in the liver. Such 
an abscess may be bacterial 
(pyogenic) , parasitic, or 
fungal. The present dis-
cussion will be limited to the 
pyogenic type. Further, this 
paper will focus on the 
changes in epidemiology and 
etiology, and the recent 
advances in diagnosis and 
treatment. 
EPIDEMIOLGY 
by Glen Hooker, Meds '94 
renal infection, or pneumonitis. In 
infants, bacterial seeding through the 
hepatic artery may occur secondary 
to umbilical vein catheterization.6 
In the United States, 
pyogenic abscesses account 
for 80% of all liver abscesses; 
Figu re 1: The liver is riddled with multiple abscesses, 
secondJJry to a stone in the common bile duct. 
The presentation of bacteria to 
the liver is insufficient to cause 
pyogenic hepatic abscess; susceptible 
liver parenchyma is required as well. 
Examples of vulnerable liver states 
include obstructive biliary disease, 
biliary infections, and liver trauma. 
In obstructive biliary disease (e.g . 
cholelithiasis, obstructive malignancy 
of common bile duct or pancreas; see 
Fig. 1), or biliary infections (empyema 
of the gallbladder, cholangitis), 
bacteria multiply in the bile ducts, 
and ascend into the liver via the bile 
ducts. In addition, portal and 
pyogenic abscesses occur in 8-15 people per 100,000 
population.1 The incidence is higher in countries where 
medical care is not readily available.2 Despite recent 
advances in diagnosis and therapy, the incidence of 
pyogenic liver abscess has remained stable, probably 
due to increased survival of patients who have intra-
abdominal diseases.2 Males are affected more than 
females (3:2 ratio) .3 The peaks of occurrence are during 
the first year of life and between 60 and 80 years of 
age.4 There appears to be no racial susceptibility.S 
PATHOPHYSIOLOGY 
In order for a pyogenic liver abscess to develop, at 
least two pathologic processes must occur. The liver 
must be both exposed to bacteria and vulnerable in 
some way to the bacteria. 
Bacteria may reach the liver via the portal vein, the 
hepatic artery, the biliary tree, or by direct spread. 
Portal venous spread starts as thrombosis of mesenteric 
veins at the site of an inflammatory process, commonly 
an intra-abdominal infection such as appendicitis or 
diverticulitis. Septic emboli, which reach the liver via 
the portal vein, are subsequently formed creating foci of 
intense inflammation in the liver. These foci coalesce to 
form an abscess. Bacteria may reach the liver via the 
hepatic artery, as in the case of generalized sepsis 
secondary to conditions such as bacterial endocarditis, 
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lymphatic invasion by these bacteria produce pus, which 
enters the liver directly . Trauma is associated with 
increased risk of developing a liver abscess via bile 
leakage, decreased perfusion, hepatic necrosis, direct 
introduction of bacteria , and hematoma formation. 
About one-quarter of all liver abscesses are cryptogenic 
in origin, with no underlying source identified, even 
after visual and manual exploration of the abdomen? 
In adults, conditions associated with the formation of 
pyogenic hepatic abscesses include malignancy being 
treated with chemotherapy, colon cancer, diabetes 
mellitus, and cardiopulmonary disease. In children, 
associated conditions include malignancy, AIDS, 
polycystic disease, cholecystitis, necrotizing 
enterocolitis, and non-AIDS immunodeficiency states 
(e.g. chronic granulomatous disease).B 
Normally, an efficient clearing mechanism, involving 
scavenging reticuloendothelial Kupffer cells, prevents 
colonization of liver parenchyma by bacteria. But when 
the presence of bacteria in the liver is complicated by 
the presence of necrotic tissue, hepatic injury, malignant 
tumours, microemboli, poor perfusion, or biliary or 
vascular obstruction2, the bacteria are able to multiply, 
invade liver parenchyma, and form an abscess. 
PATHOLOGY 
Grossly, hepatic absce ses are more likely to appear 
on the right side of the liver than the left by a 3:1 ratio.9 
Perhaps this difference is due to streaming of the 
superior mesenteric vein fraction of portal flow into the 
right lobe of the liver. lO Multiple abscesses occur as 
often as solitary abscesses.2 (see table 1) A solitary 
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abscess may vary in size from a few millimetres to 
several centimetres. The liver itself may be enlarged 
and adherent to surrounding organs due to capsular 
inflammation2. Microscopically, the liver will display 
an acute inflammatory reaction with necrosis and 
hepatocyte cords in the portal triad regions.2 
M ICROBIOLOGY 
Ln more than half of patients with liver abscess, the 
abscesses contain more than one organism when the 
abscess contents are cultured. Specific organisms 
recovered vary greatly. 
Organisms found generally reflect biliary or enteric 
flora . The most common aerobic organisms are E. coli, 
Klebsiella , and enterococci (e.g. Streptococcus faecalis). 
The most common anaerobes are Bacteroides, anaerobic 
streptococci (e.g. Peptostreptococcus), and Fusobacterium 
spp. Isolated colonies of E. coli or Klebsiella are 
suspicious for a biliary source, whereas anaerobe-
positive cultures are suggestive of a colonic source2. 
Staphylococci, hemolytic streptococci, or other gram-
positive organisms are found if the primary infection is 
bacterial endocarditis or pneumonitis. Recent studies11 
using improved culture techniques have found non-
hemolytic streptococci and normal oral flora to play a 
more prominent role. 
There appears to be an increase in the number of 
cultures posi tive for anaerobic and microaerophilic 
organisms. Possibly, this increase is secondary to 
improved culture techniques. Cultures positive for 
anaerobes are usually positive for other organisms as 
well; thus, broad-spectrum therapy is usually required 
if anaerobes are present.12 
D IAGN OSIS 
Hepatic abscess is associated with a number of 
symptoms and signs. Symptoms include fever (often 
erratic, and spiking to 40-41 "C), chills, rigors, right 
upper quadrant pain, malaise, fatigue, weight loss, 
night sweats, nausea, and vomiting. Physical findings 
include right upper quadrant tenderness, ple ural 
dullness to percussion, hepatomegaly, and jaundice.? 
A number of cellular changes occur which may aid 
diagnosis of pyogenic hepatic abscess. For example, a 
leukocytosis of greater than 15x109 / L (often with left 
shift) and anemia of chronic disease are present in most 
patients . Most patients have an elevated alkaline 
phosphatase and an elevated gamma-glutamyl 
transpeptidase (_-GTP) since a liver abscess is a space-
occupying lesion.12 In some patients an increase in 
aspartate aminotransferase (AST) and al a nine 
aminotransferase (ALT) may be observed. An elevated 
total bilirubin may be seen in cholestasis secondary to 
hepatic structural collapse. Blood cultures are positive 
for bacteria in about half of patients. Percutaneous 
aspirates from the abscesses are positive for bacteria in 
about three-quarters of patients .13 Aspirat i ng a 
pyogenic liver abscess reveals a malodorous exudate.? 
The clinical syndrome of a pyogenic abscess often 
cannot be distinguished from that of an amoebic 
abscess. Since aspiration of an amoebic abscess can lead 
to secondary infection, especially in geographic areas 
with a large immigrant population, eliminating this 
possible diagnosis is important. Appropriate serologic 
tests such as the indirect hemagglutination test are 
useful in the diagnosis of an amoebic abscess.14 
In addition to clinical findings, and altered 
biochemical levels, a number of imaging techniques are 
available which may aid in the diagnosis of pyogenic 
hepatic abscess. These techniques include ultrasound, 
computed tomography, invasive techniques, plain 
radiographs, and radionuclide isotope scanning. 
Ultrasound has an 85-95 % sensitivity for th e 
detection of hepatic abscesses and is the most useful 
screening test when an hepatic abscess is suspected. 
Ultrasound is cost-effective, more accurate than CT in 
imaging the biliary tree, and allows for diagnostic or 
therapeutic drainage or biopsy to be performed during 
the scan. Ultrasound may also be used intraoperatively 
to locate small or deep abscesses in the liver. 15 
Ultrasound, however, may fail to detect an abscess in a 
liver that is inhomogeneous or high beneath the 
thoracic cage. 
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Table 1 TREATMENT 
Drug Therapy for Pyogenic Hepatic Abscess 
Pathogens 
Gram-negative rod (44%) 
Escherichia coli 
Klebsiella pneumoniae 
Antibiotic Agents 
Treat with ingle agent: 
Ampicillin- ulbactam (Unasyn) 
or 
Ticarcillin-potas ium clavulanate (Timentin) 
or 
The treatment of the 
abscess includes intravenous 
antibiotics and drainage . 
Treatment should be 
individualized for each 
patient. 
Antibiotics should be 
given immediately, by the 
parenteral route, starting with 
a broad coverage regimen 
consisting of a penicillin, an 
aminoglycoside, and 
clindamycin or metroni-
dazole. Adjustment of this 
regimen depends on culture 
results of abscess aspirates 
(see Table 1).6 If cultures are 
steri le but a clinical diagnosis 
of hepatic abscess remains, 
broad-spectrum antibiotics 
sho uld be maintained . 
Antibiotics should be given 
for at least three weeks20; 
some physicia ns recommend 
therapy for up to 12 weeks. 
Antibiotics hould be given 
lmjpenum-cilastatin (Primaxin) 
Treat with two agents: Gram-po itive cocci (40%) 
Streptococcus spp. 
Staphylococcus spp. 
Second- or third-generation cephalo porin plus 
metronjdazole (Fiagyl) or clindamycin (Cleocin) 
or 
Ampicillin plus chJorampherucol (ChJoromycetin) 
Treat with three agents: Anaerobic organi m (8%) 
Bacteroides spp. 
Clostridium spp. 
Peptostreptococcus spp. 
Ampicillin or antip eudomonal perucillin plus 
a econd- or third-generation cephalo porin or an 
aminoglycoside plus metrorudazole or clindamycin 
Microaerophjlic 
organism (6%) 
Streptococcus milleri 
Streptococcus mitis 
U e arne treatment as for anaerobic organi ms 
Computed tomography (CT) is the diagnostic 
technique of choice. Its sensitivity is 95 %, and its 
specificity is 92% for single abscesses and 100% for 
multiple abscesses.16 When used with contrast, CT will 
show the relative hypovascularity a t the location of the 
abscess. CT also allows for simultaneous diagnostic or 
therapeutic intervention. 
Endoscopic retrograde cholangiopancreatography 
(ERCP) and percutaneous tra n s hepati c 
cholangiography (PTC) are invasive techniques which 
are useful if biliary obstruction and ascending 
chola ngiti are suspected . The e carry the ri sk of 
dissemination of infection . Angiography involves 
fewer complication and ma y be 100% sensitive for 
detection of hepatic abscesses.1 7 
Chest x-ray is abnormal in about half of patients, but 
is neither ensitive nor specific fo r pyogenic hepatic 
abscess.1 8 X-ray ma y s how right hemidiaphragm 
eleva tion, pleural effusion, and basilar atelectasis or 
infiltrate.14 A plain abdominal film may show gastric 
displacement due to liver enla rgeme nt1 8, and 
occasionally an air-fluid level in the region of the liver, 
representing an abscess. 
Radionuclide isotope scanning uses labelled tracers 
that are concentrated in h e patocy te s or 
reticuloendothelial cells. The e scans are 80-90 % 
sensi tive, but are unable to detect small lesions and are 
unable to discriminate betwee n solid and cystic 
tructures.1 7, 19 
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for 1-2 days before drainage is begun2. Oral therapy 
may be u ed in the final week or two of treatment if 
clinical improvement continues. Antibiotic trea tment 
alone, without drainage, has been referred to in the 
past as a "last resort" in the primary treatment of these 
abscesses, and several studies proclaim its 
inadequacy.2,13,15 Recently, however, that drainage is 
necessary only if the pati e nt does not respond to 
antibiotics within 48 hours , or if the patient 
deteriorates clinically, has been suggested.21 In the 
case of microabscesses, where drainage is difficult by 
any method, antibiotics alone are the mainstay of 
therapy . Monitoring the efficacy of antibiotic-only 
treatment, by sizing the abscesses using re peat 
ultrasound imaging, is imperative. 
In addition to antibiotics, drainage of the abscess is 
also critical to a successful treatment outcome . 
Drainage may be percutaneous or open. Two decades 
ago, open drainage was much more common than 
percutaneous drainage as a primary therapy. Through 
the 1980' s, the two were performed on an equal basis? 
Percutaneous drainage became more popular in the 
late 1970' as an adjunct to open drainage and as a 
primary treatment. Percutaneous drainage is the 
current "gold standard" for diagnosis of a pyogenic 
hepatic abscess, 6 and is 86-92 % s uccessfu l as a 
treatment. Percutaneous drainage involves first 
localizing the abscess under ultrasound or CT 
guidance. A tract to the abscess is then produced using 
a needle, guide wire, and dilator; a drainage catheter is 
subsequently inserted into the cavity. Such a catheter 
would be left in place for 2-3 weeks; early removal is 
associated with recurrence of abscesses.22 This type of 
drainage may be used as definitive therapy, or pre-
operatively before open drainage either if the patient is 
not responding to antibiotics or a search for the 
primary site continues. The percutaneous method of 
drainage is ideal for abscesses which are solitary, 
accessible by needle, deep-seated, or adherent to the 
abdominal wall? With this method, however, there is 
an increased likelihood of secondary procedures; as 
well, the underlying source of the abscess may remain 
unknown. Further, failure of this method may result if 
the abscess is multiloculated, if its contents are too 
viscous to drain via a catheter, or if the catheter is 
dislodged from the abscess.23,24 
Open drainage is the classical treatment of liver 
abscesses . This method is ideal for concurrent 
drainage of another (e.g. appendiceal) abscess, 
drainage of multiloculated abscesses, or those that are 
not easily accessible by needle . Open drainage is 
usually undertaken on a patient after the percutaneous 
method had failed2. Open drainage is associated with 
a higher rate of complications and mortality. Thus, 
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raw co mpari sons of s urgical versus percutaneou s 
treatment are not appropriate without consideration of 
underlying conditions and location and accessibility of 
ab cesses . Complications include septicemia (most 
common ), effusions, empyem a, rupture into right 
ubphrenic space, and pneumonia.? Three methods of 
open drainage exist: the transpleural approach, which 
is useful for high posterior lesions; the transperitoneal 
approach, which is the most preferred method since it 
allows inspection of the entire abdominal cavity for an 
underlying source, and provides the best mobilization 
of o r ga n s for drainage; and the extraperitoneal 
approach which may begin posteriorly near the 12th rib 
or via an anterior retroperitoneal dissection.2 
Recent suggestions16 for treatment have included 
the use of laparoscopic investigation for liver abscesses. 
Many patients with liver abscesses, however, have 
dense right upper quadrant adhesions or abscesses, 
which would preclude s u ccessful laparoscopic 
aspiration. Resection of a portion of liver containing an 
abscess or ab cesses is reserved for areas of infection 
econdary to hepatic malignancy, or those associated 
with granulomatous disease of childhood .2 
PROGNOSIS 
Survival has improved due to earlier diagnosis and 
treatment. Sixty years ago the mortality was 80%, but 
it is now less than 20%. The primary determinant of 
prognosis seems to be the underlying condition, with 
malignancy or immunocompromise having the highest 
mortality. Prognostic factors include size of abscess, 
number of abscesses, patient age (more complications 
in infants and elderly), multiplicity of organisms, 
tim e liness of diagnos is, and presence of 
immunosuppression or malignant disease .14,25 If a 
pyogenic abscess is left untreated, death occurs in 10-
30% of patients who have no complications, and in 73% 
of patients wi th complications (e.g. rupture, sepsis, 
hepatic or renal failure)_4,18,26 
SUMMARY 
Despi te advances in diagnostic technology and new 
strategies for treatment, the diagnosis and management 
of hepatic abscess remains challenging. Ultrasound and 
CT have made possible the detection and early 
treatment of pyogenic heaptic abscess,27 thus yielding 
improved clinical results.24,28,29 But the incidence of the 
disease is not decreasing, and the commonly associated 
factors of malignancy, immunocompromise, and 
advanced age, are playing a more prominent role in the 
etiology. The standard of care remains timely diagnosis 
and prompt institution of trea tment. The choice of 
therapy shou ld be individualized to the pa t ient, 
considering solitary versu s multiple abscess, w hether 
additional problems requiring surgery are present, and 
the nature of the underlying disease. Morbidity appears 
to be related to the treatment method, but mortality is 
related to the underlying disease. 
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THE 
ABSTRACT 
DIAGNOSIS 
OF SEPTIC 
T 'he causative agents, demographics and outcome of septic arthritis have changed over the last several years. Staphylococcus aureus remains the most 
common cause of septic arthritis caused from nongonococcal 
organisms. Meth icillin -res istant joint infections with 
Staphylococcus aureus have been increasing. Due to better 
culturing methods more anaerobic cases of septic arthritis 
are being identified. The most common joint involved in 
septic arthritis in adults is the knee. However, there are 
exceptions in certain populations. Intravenous drug use is a 
risk factor for septic arthritis, often invo lv ing 
fibrocartilaginous joints such as the sternoclavicular and 
sacroiliac joints. The outcome in these patients is usually 
excellent. The functional outcome of a septic joint is usually 
good if the diagnosis is made within two weeks of disease 
onset. The morbidity with gram negative bacteria is usually 
higher than with gram positive cocci. Debate about when to 
intervene surgically in the treatment of septic arthritis 
continues. 
INTRODUCTIO N 
There has been little change in the total number of 
cases of bacterial arthritis1 but certain infections are 
increasing such gram negative bacilli and non-group A 
streptococci, whereas pneumococci are relatively rare 
in septic arthritis now. Anaerobes have been cultured 
more frequently which may reflect better culture 
techniques. Within certain populations, there may be 
specific types of bacterial infections, su ch as 
Staphylococcus aureus (S. aureus) and pseudomonas in 
intravenous drug users. So far, there have not been 
observations of increased septic joints in HIV positive 
patients, but with AIDS becoming a more chronic 
disease, it may be tubercu lous arthritis or other 
atypical bacterial joint infections may increase in this 
immunocompromised population. Bacterial arthritis is 
the most rapidly destructive form of arthritis. There 
are two major types of bacterial arthritis: arthritis from 
Neisseria gonorrhoeae and other bacterial arthritis. 
The former arthritis is usually more benign and will 
not be discussed in this review. The pathophysiology, 
diagnosis and treatment of septic arthritis is discussed. 
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AND TREATMENT 
ARTHRITIS 
by Janet Pope, M.D., MPH, FRCPC 
PATHOPHYSIOLOGY 
Mos t cases of septic arthritis have resulted from 
bacterial hematogenous spread. Fewer cases occur from 
direct spread from joint trauma, arthrocentesis, or local 
osteomyelitis. Within two days after injection of S. 
aureu s into a rabbit joint, polymorphonuclear 
infiltration and synovial lining cell hyperplasia occurs.2-4 
Chondrocyte necrosis can occur in two days. Abscesses 
develop within the joint space. Irreversible joint 
destruction can occur as early as one week after the 
onset of infection. 
Joints that are damaged are predisposed to infectious 
arthritis. Rheumatoid arthritis is a risk factor for septic 
arthritis, as is gout, chondrocalcinosis and 
osteoarthritis. Intravenous drug abusers are at risk due 
to recurrent bacteremia. People with sickle cell disease 
are at risk for certain types of infections including 
salmonella osteomyelitis or septic arthritis. O thers with 
chronic disease who are immunosuppressed are at an 
increased risk. These include people with systemic 
lupus erythematosu s, cancer, alcoholism and renal 
transplantation . The very young and old are at an 
increased risk of septic arthritis due to impaired host 
defenses. 
The joints commonly involved in adults are the knee 
and the hip. Children also have these joints involved 
but have bacterial hip arthritis slightly more often than 
what occurs in adulthood . See Tab le 1 for the 
frequencies of joint involvement. Eigh ty to ninety 
percent of septic arthritis is monoarticular. In those 
with more than one joint involved, the most common 
organism is still S. aureus and then streptococcus 
Table 1 
Joints involved in Septic Arthritis 
Percentage of Cases 
Joint Adult Children 
Knee 55 40 
Hip 11 28 
Ankle 8 14 
Shoulder 8 4 
Wrist 7 3 
Elbow 6 11 
Others 5 3 
More than one joint 12 7 
40 
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Organisms in Septic Arthritis 
Feature Sect i on 
limited passive and active ra nge of 
motion. The mortali ty rate is doubled 
in those with polyar t icu lar 
involvement.S Most patients a re 
Adults(%) Children(%) febrile . The differential diagnosis includes o ther infla m mator y 
arthropathies. See Table 3 for a list of 
differential diagnoses. On physica l 
examination, a source of the infection 
should be looked for as most of the 
cases are from hematogenous spread. 
In children, otitis media and 
meningitis should be ruled ou t if H . 
influenza is suspected. Over half the 
patients with septic arthritis have a 
peripheral leukocytosis.? Both blood 
and synovial fl u id cultures are 
important for diagnosis. Blood 
cultures which are positive in 30 to 
60 %8,9,10 of cases should be done. 
Gram Positive Cocci 
S.aureus 35 
S. pyogenes, S. pneumoniae, 10 
S. viridans Group 
GramNegative Cocci 
gonnorrhoeae and meningitidis 50 
H. influenzae <1 
Gram Negative Bacilli 
E coli, Salmonella and 
Pseudomonas species 5 
Mycobacteria and Fungi <1 
pneumoniae (S. pneumoniae), group G streptococci and 
Haemophilus influenzae (H. influenzae).S 
Aside from is eriae gonorrhoeae ( . gonorrhoeae), 
the most common cause of septic arthritis is S. aureus 
which occurs in approximately 70% of other bacterial 
arthritis in adults and 27% of childhood cases.6 Young 
children less than five years of age are at risk for H. 
influenzae which is frequently accompanied by 
concurrent infection such as otitis media or meningitis. 
Other gram negative organisms occur rarely in septic 
joints. However, intravenous drug abusers are at an 
increased risk of S. aureus in orne East coast cities and 
p eudomonas in the western United States and in 
Detroit. Table 2 lists the prevalences of certain bacterial 
pathogens in adults and children w:ith septic arthritis. 
DIAGNOSIS 
A septic joint usually pre ents with an acute tense 
effusion, warmth, erythema, inten e pain and markedly 
Table 3 
Differential Diagnosis of Bacterial Arthritis 
Gout 
RA 
Lyme Disease 
Viral Arthritis 
P eudogout (Chondrocalcino is) 
Reiter's Syndrome 
Acute Tramatic or Hemerrhagic Arthritis 
Bacterial Endocarditis w:ith Embolization 
Rheumatic Fever 
Osteomyelitis ear Joint 
27 
16 
8 
<40 
9 
<1 
Cultures of other areas such as urethra 
and cervix are important to rule out 
gonococcal infection . Any symptomatic areas should be 
cultured such as sputum if the patient has pneumonia, 
and urine and skin ulcers where indicated . Baseline 
radiographs should be done. The presence of an 
effusion i common but erosions are not usually seen 
early on radiographically. The joint should be aspirated 
and fully drained. 
Synovial fluid is often cloudy. The fluid should be 
ent for gram stain, culture and sensitivity, acid fast 
culture w here indicated , white blood cell count and 
differential, red blood cell count, and crystal analysis. 
The gram stain is positive in 50 to 60 % of 
nongonococcal septic arthritis_8,11 ,12 The white count is 
greater than 50,000/mm3 in 70%.13 The presence of red 
blood cells in a joint with no history of trauma is 
correlated with an increased risk of septic arthritis . 
Therefore, any bloody synovial fluid should be sent for 
culture. The p resence of crystals does not rule out 
septic arthritis. Acute gouty arthritis can also have high 
white counts, o the diagnosis of septic arthritis should 
be entertained in a patient with gout who is having an 
acute flare-up .13 Polymorphs are abundant with a 
synovial fluid differential of greater than 80 % and 
usually greater than 95% polymorphs are seen.13 
The synovial glucose i often les than half of the 
serum glucose .14 However this is not definitive as 
several patients with rheumatoid arthritis have a low 
glucose. This test is also not sensitive. If the diagnosis 
of septic arthritis is uspected but not confirmed by the 
u ual te t , then it may be worthwhile to do a gallium 
scan which if negative, rules out eptic arthriti . 
Us ually this is not necessary. Gallium scans are 
sensitive in detecting septic arthritis but are not specific. 
Other imaging modalities are usually unnecessary for 
the diagnosis of septic arthritis. 
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TREATMENT 
Treatment is both local and systemic. A septic joint 
should be repeatedly aspirated as th e effusion 
reaccumulates. Subsequent fluid gram stains, cultures, 
white counts and percent polymorphs should be 
followed and improvement implies successful therapy. 
The joint is rested with initial passive range of motion a 
few times a day. There should be no weight bearing for 
several days. The joint may be splinted, but not in a 
flexed position or the chance of a flexion contracture 
occurring is increased. Systemic high dose antibiotics 
are given often for up to four weeks in nongonococcal 
bacterial arthritis. Table 4 lists possible antibiotic 
choice to initiate according to the gram stain and the 
patient' s demographics. 
There is debate in the literature about when surgery 
should be the initial treatment for septic arthritis. Any 
joint which is difficult to aspirate and to follow 
clinically, should be treated with urgical drainage. 
Septic hips are often drained fluoroscopically or by 
ultrasound guidance in children. If gas forming 
bacteria are seen on radiograph, this would be an 
indication for urgent surgical debridement. A post-
operative drain is usually inserted . For the surgical 
treatment of septic arthritis, arthro copically drained 
joints are being performed commonly now and open 
arthrotomies are decreasing. Failure of a ntibiotics 
(persistently positive joint cultures) is an indication for 
su rgery. Many of these cases have small synovial 
abscesses for which a partial synovectomy is 
performed. In a review of the case series i n the 
literature, Goldenberg et al found that 80% of patients 
treated medically had complete recovery compared to 
47% with surgical treatment.1 5 There may have been 
selection bias where only sick patients with more severe 
Table 4 
Examples of Empiric Antibiotic Treatment 
Gram Stain Treatment 
Gram Positive Cocci Cloxacillin 
Vancomycin 
Cephalosporin 
infections were treated surgically. However, because 
there are no randomized trials comparing surgical to 
medical treatment, this is the best information to date. 
Therefore, in most cases of septic arthritis, the initial 
treatment is medical. 
Delay in antibiotic treatment is proportional to poor 
outcome.8 If antibiotics are begun within two weeks, 
67% of septic joints were found to have complete 
functional recovery. Whereas, only 27% of joints had 
complete functional recovery if treatment was initiated 
more than two weeks after the onset of symptoms . 
Mortality rate in septic arthritis is increased in the 
elderly (up to 25 %), in those with several joint 
involved and in those with comorbidity.11 ,16 Several of 
these risk factors for poor outcome are correlated . 
Functional recovery is decreased in gram negative 
arthritis compared to gram positive. Intravenous drug 
abusers who are otherwise well have an excellent 
recovery in general and may only require therapy for a 
couple of weeks. These patient are often otherwise 
young and healthy and have only transient bacteremia 
with a less severe form of septic arthritis often in small 
fibrocartilaginous joints such as the sacroiliac joint. A 
short duration of treatment is usually successful in 
eradicating the infection; this is fortunate since 
compliance can be poor. 
Sequelae of septic arthritis include flexion 
contractures, ankylosis, erosive arthritis, sterile post-
septic synovitis, decreased range of motioQ of the 
involved joint and local muscle wasting. Rarely 
osteomyelitis occurs secondary to an adjacent septic 
arthritis. 
SPECIAL CONSIDERATIONS 
GRAM EGA TIVE SEPTIC ARTHRITIS 
Gram Negative Bacilli Pipercicillin and Tobramycin 
Moxalactam 
There are four groups who are at risk for 
gram negative septic arthritis. Infants less than 
two months are susceptible to gram negative 
bacteremia and can develop septic arthritis. 
Young children have an increased incidence of 
H. influenza infections. There has been some 
ampicillin-resistance of H . influenza over the 
last decade, so the initial treatment for this 
infection is often with a third generation 
cephalosporin. With the vaccination against H. 
influenza now being widely administered to 
children in the first year of life, H. influenza 
septic arthritis could become quite rare. The 
elderly, especially those with underlying 
arthritis have an increased risk of acquiring a 
gram negative joint infection often from 
urinary tract infections or diverticulitis with 
septicemia. In some areas, intravenous drug 
users have pseudomonal infections. The 
immunocompromised are at increased risk for 
bacterial joint arthritis including gram negative 
infections. 
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Cefotaxime 
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RHEUMA TOlD ARTHRITIS 
Pa tients w ith rheuma toid arthritis (RA) a re a t a n 
in creased ri s k of septic a rthr iti s. The s ig n s a nd 
symp toms of septic arthritis could be masked in these 
patients due to their underlying arthritis, use of s teroids, 
and d e bilita tion . In RA , 50 % of p a ti e nts have a 
periphera l leukocy tos is.? The m os t common joint 
involved is s till th e knee (50 % to 75 % in ca ses 
eries),17,18 howeve r th e e lbow is a lso frequ e n tly 
involved (13 to 38% of cases of septic arthritis in RA). 
There is an increased tendency for multiple joints to be 
involved ,19-21 and in one series, 70% had polyarticular 
sep tic arthritis.22 Most septic join ts in RA originate from 
bac te r e mi a . The diag nosis is su s pec ted whe n 
in fla mmation and pain are g rea te r than the patient's 
other joints. The causative organism is s till most often S. 
aureus, occurring in over 80% of cases.8,9,12,19,22-24 The 
synovial fluid white cell count may delay the d iagnosis, 
as 4% of pa tients with RA without an infection may 
have a white count of greater than 50,000/ mm3. 
JOINT PROSTHESES 
Prosthe tic joint infections have decreased in the 
acute post-operative time due to antibiotic prophylaxis, 
a nd ne w techniques in th e o p e ra ting room . The 
infec tion rate is now 0.5 to 4%.25-29 The acute infection 
is o ften from staphylococcus epidermidis . Subacute 
infec tions can occur in the latter half of the first year 
po t-o peratively. These infecti o n s a re difficult to 
d iagnose and may show loosening on radiograph with 
pain and joint swelling. Later infections are often from 
bac te remia (such a s pos t ins trumentation) and are 
u su a lly caused b y S. au reu s. Trea tment involves 
prolonged use of antibiotics. Sometimes the joint has to 
be removed . However, the a rea need s to be s te rile 
before another prosthesis is reinserted. In patients with 
RA, the risk of pros the tic joint seps is is three-fold 
increased compared to osteoarthritis.25,29,30 It may be 
the syste mic abnormalities of RA that increase the 
general risk for a prosthetic joint to become infected . 
Some physicians routinely prophylax patients with 
pro thetic joint replacements prior to instrumentation 
a nd dental work, with a protocol similar to patients 
receiving prophylaxis for abnormal heart valves. This 
prac tice is currently not universa l and needs more 
investigation before becoming routinely advoca ted . 
CONCLUSIONS 
Septic arthritis is still relatively common. S. aureus 
re mains the mos t common ca u sative organi sm . 
Mo noarticula r infections occur in the majority o f 
pa tien ts. The usual joints involved are the knee and the 
hip . The major risk factors fo r septic a rth ri ti s are 
abnormal joints, immu nocompromise and bacteremia. 
The diagnosis is made by a positive joint culture and 
g ram stain is often positive. Some antibiotic-resis tant 
o rga nis m s h ave increased in prevalence . Specific 
Feature Section 
therapy should be performed using knowledge of the 
loca l end emic bacte ri al p reva lences and resis tances. 
The prognosis is good in most cases if antibiotic therapy 
is initia ted promptly. 
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O T I T I S M E D IA 
INTRODUCfiON 
O titis media is a common problem presenting to primary care and emergency physicians. In Canada, the most frequent diagnosis for which 
antibiotics are prescribed among pre-school children is 
otitis media. Up to 20% of all visits to primary care 
physicians in Ontario are for the therapy or follow-up 
of otitis media. Thus primary care physicians should be 
comfortable with the management and follow-up of 
otitis media. 
PATHOPHYSIOLOGY 
Acute otitis media is an infection involving the 
middle ear, usually of bacterial origin. Among 
toddlers, this infection is commonly related to 
Eustachian tube dysfunction. Eustachian tube 
dysfunction is more common among toddlers for a 
number of reasons, including the relatively horizontal 
location of the Eustachian tube in young children and 
the relatively large size of periadenoidal lymphatic 
tissue. Eustachian tube dysfunction is also common 
after upper respiratory tract infections. In addition, 
there are some groups, such as children with Down's 
Syndrome, who are at high risk for Eustachian tube 
dysfunction. 
There are three bacterial species commonly found 
among children with acute otitis media; Streptococcus 
pneumoniae, Haemophilus influenzae, and Branhamella 
catarrhalis. Among these organisms, there are 
appreciable rates of beta-lactose activity among 
Haemophilus influenzae and Branhamella catarrhalis. 
Otitis media caused by Haemophilus influen zae is 
relatively more common among infants and toddlers. 
PRESENTATION 
There are three principle presentations of bacterial 
otitis media, acute otitis media, resistant otitis media, 
and recurrent otitis media. The first, and most common, 
is acute otitis media, in which a child develops an acute 
bacterial infection in the middle ear (often after a viral 
upper respiratory infection). This acute presentation is 
manifested clinically as pus in the ear, often associated 
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IN CHILDHOOD 
by Michael]. Rieder, MD, PhD, FRCPC 
with fever and occasionally accompanied by vomiting. 
The natural history of acute otitis media is that, if 
untreated, the vast majority of these infections will 
resolve, often after rupture of the tympanic membrane. 
However, without antibiotic therapy, children tend to 
have somewhat longer periods of pain and distress than 
when treated. In addition, the complications of acute 
otitis media, including meningitis and cholesteatoma 
formation, appear to be much more common among 
untreated children. 
After antibiotic therapy is instituted, a clinical 
response is anticipated in 24 to 48 hours. If the child 
has not improved, or if the child deteriorates, then the 
child should be considered to have resistant otitis 
media. In this type of presentation, the child's otitis 
media is likely caused by an organism resistant to the 
antibiotic prescribed. 
The final presentation of otitis media is that of a 
child whose otitis media responds to therapy, but, 
shortly after therapy ends, another episode develops. 
In this case, the child has recurrent otitis media . 
Recurrent otitis media may be due to the presence of 
special risk factors for otitis media, such as Down's 
Syndrome, allergies, or adenoidal hypertrophy. 
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Table 1 
Antibiotic Doses for Otitis Media 
Frequency of 
Feature Section 
recurrent otitis media. 
Recurrence and frequency 
warrant consider-ation for low-
dose prophylactic antibiotic 
Daily Dose Administration 
therapy or for surgical 
placement of myringotomy and 
tympanos-tomy tubes. The 
only antibiotics which have 
been evaluated in this role have 
been amoxicillin and co-
trimoxazole . Hopefully, the 
development of vaccines may 
resolve some of these 
therapeutic dilemmas. 
amoxicillin 25 mg/kg/ day 3 times per day 
co-trimoxazole TMP 6 mg/kg/ day 2 times per day 
erythromycin/ suliamethoxazole eryth: 40 mg/kg/ day 3 times per day 
(Pediazole) 
pivampicillin 
amoxicillin/ clavulanate 
cefaclor 
cefixine 
THERAPY 
50 mg/kg/ day 
20 mg/kg/ day 
25 mg/kg/ day 
8 mg/kg/day 
The mainstay of therapy for acute otitis media is the 
use of oral antibiotics. Traditionally, the use of an 
aminopenicillin drug such as amoxicillin has been the 
usual first-line therapy for otitis media (see Tables 1 
and 2) . In the case of penicillin-allergic patients, co-
trimoxazole (Septra or Bactrim) or erythro-
mycin / sulfamethoxazole (Pediazole) should be used. 
For resistant otitis media, an antibiotic should be 
chosen which has a different bacteriological spectrum 
from the antibiotic originally prescribed. There are a 
number of antibiotics available as secondline therapy, 
including cefaclor, cefixine, amoxicillin/ clavulanate, co-
trimoxazole and erythromycin / sulfamethoxazole. 
The same consideration for changing antibiotic 
therapy apply in the case of the acute therapy of 
Table 2 
2 times per day 
3 times per day 
3 times per day 
1 time per day 
Antipyretic and 
analgesic therapy is important 
in the symptomatic therapy of 
otitis media. Acetaminophen is 
the mainstay of therapy in a 
dose of 15 mg/kg/dose given 
every 4 hours as needed. In the 
unusual case where a child 
who has had adverse reactions to acetaminophen , 
naprosyn 20 mg/kg / day divided into two to three 
doses a day can be used . For single-dose therapy 
immediately after diagnosis, a single dose of 1 mg/kg 
of codeine can be used. 
Patients with acute otitis media should have clinical 
improvements in 24 to 48 hours. If the patient has not 
improved at that time, or if the patient deteriorates, the 
patient should be seen again. If the patient's symptoms 
resolve, the patient should be seen in follow-up in two 
to three weeks. A sterile effusion may persist for up to 
six weeks after as episode of acute otitis media. Fluid in 
the middle ear that is not associated with symptoms 
may not require therapy, but it does need follow-up, 
especially with respect to the potential for hearing loss. 
In the case of recurrent otitis media, follow-up will 
have to address the potential need for insertion of 
tympanostomy tubes. 
Cost of 10 Days of Therapy (10 kg child) REFERENCE 
amoxicillin 
co-trimoxazole 
(Septra, Bactrim) 
Cost of Drug 
2.19 
1.59 
erythromycin/ suliamethoxazole 
(Pediazole) 
10.99 
pivampicillin 
amoxicillin/ clavulanate 
cefaclor 
cefixine 
9.57 
7.75 
11.43 
14.58 
Dispensing Fee (Average) 
10.00 
10.00 
10.00 
10.00 
10.00 
10.00 
10.00 
Bluestone, Charles . 
Modern Management 
of Otitis Media . 
Pediatric Clinic of North 
America .. 36:1371-1388 
(1989). 
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A SAMPLE OF INFECTIOUS DISEASES 
RESEARCH IN PERU 
The following is a sample of eight concurrent research projects I was exposed to when I travelled to Peru in the summer of 1992 and s tayed with Professor 
Robert Gilman, MD of John's Hopkins University. Dr. 
Gilman has lived in Lima for eight years engaged in 
research and publishing papers. In addition to Hopkins, 
Peruvian universities Universidad Peruana Cayetano 
Heredia, and Universidad San Marcos arecentres that 
have been associated with work in infectious d iseases. 
Also involved is Prisma, a well established third world aid 
and development organization supported in large part by 
American grants and directed by Dr. Gilman's wife . The 
wide diversity of tropical infective disease, coupled with 
the effects of altitude which can be observed in the Andes 
make Peru an atractive research arena for the infective 
disease specialist. 
Helicobacter pylori (HP) 
The relationship between HP, atrophic gastritis, and 
gastric ulcer has been known for over five years, but is 
only just now becoming accepted in North American 
Centres. The further likely relationship between HP and 
gastric cancer is the subject of resea rch effort by Dr. 
Gilman. In the third world HP infection rates typically see 
most of the population infected by age 20, and in some 
places 50% of the population are infected before one year 
of age. Rates of gastric cancer are higher and those of 
peptic ulcer lower than in the first world. 
Cholera 
Over a year and a half of water and sewage sampling 
has provided support for the use of sewage monitors to 
predict cholera outbreaks. Also bioimpedance monitoring 
has allowed better determination of the state of hydration 
of cholera patients, allowing for more effective 
rehydration. 1 
Cysticercosis 
Western blot techniques have shown that over 10% of 
Peruvians and 25% of pigs hae antibodies to T. solium. 
Current studies are examining the use of sentinel pigs to 
detect infection in endemic zones. Cysticercosis may be a 
causative factor in the development of epilepsy. 
by Ross Mantle, BSc, Meds '95 
Cyclospora cayetanesis 
A new enteropathogen first described by Dr. Gilman's 
group which is named after Universidad Cayetano 
Heredia. Work has begun on basic epidemiology and 
serology. 
Cryptosporidium 
Cryptosporidium is also an enteropathogen, but not 
fatal. Nevertheless, work on nutritional s tatus and 
diarrhea due to cryptosporidium has revealed changes in 
growth patterns. 
Oximetry 
A very useful means of determining repiratory 
decompensation in children with upper respiratory tract 
infections living at high altitude. Because the ambient 
oxygen tension is so low, patients reach the steep portion 
of the oxygen saturation curve earlier. O xi metry in 
combination with the World Health Organization (WHO) 
algorythmare a very powerful diagnostic tool. 
Tuberculosis 
Patterns of endemicity with respect to age differ in the 
third world from what might be expected in more 
developed areas. Dr. Gilman's group is working on a 
mathematical model of the epidemiology of this condition. 
Inca Peanut 
Not an infectious disease, but a potentially useful and 
valuable plant. The Inca peanut, or oilseed Plukentia 
volubilis was used to make oil by the Inca Indians . 
Research by Dr. Gilman's groups in collaboration with the 
University of Arkansas has revealed that the fruit has very 
high ratios of low saturated fats. Also, the high protein 
content is a rich source of essential amino acids. Vitamin E 
content is also high. 
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STITCHES IN 
MISADVENTURES 
T I M E I I 
IN PSYCHIATRY 
I f you asked me, as a first year medical student, what branch of medicine I planned to undertake, I would have unhesitatingly said "Psychiatry". The idea of 
flailing at the frontiers of the human psyche was 
unbelievably enthralling. Delving into the processes, 
emotions, and even the chemistry of what makes us 
unique sentient beings (at least in some cases) probably is 
the most interesting aspect of medical practice. I read the 
works of Freud, Bettelheim and Brenner and just couldn't 
wait for my first assignment at 999 Queen Street East, 
probably the most famous cookie jar in Ontario. I knew 
that things there would probably be a little bit on the 
gritty side because, after all, the truly erudite 
psychoanalytic types carried on their practices at the 
elegant Clarke Institute of Psychiatry. Nevertheless, I 
was looking forward to a calm cerebral experience 
delving into why a patient thought he was Napoleon, or 
orne other equally fascinating delusion. 
I was first greeted by the resident who explained the 
ground rules . "Whenever you are interviewing a 
patient, make absolutely certain that there is a 
telephone in the room", he explained. 
"How often do you have to call for help?" I asked. 
He gave me the strangest look. 
"You don't call for help", he said with a note of 
bored sarcasm. "If they give you trouble you pick up 
the phone and smash them in the face with it." He 
walked out shaking his head and I meekly followed. 
We walked into a patient room where there awaited our 
first subject. He was a small furtive man with greasy 
hair and eyeglasses that were at least four sizes too 
large for his face, which created a distinct owl-like 
expression. He was chain-smoking cigarettes and there 
was a large filthy ashtray in front of him, full of the 
detritus of his habit. What a pitiful-looking individual, 
I thought. A number of diagnoses went through my 
mind-neurotic? obsessive-compulsive? 
chizophrenic? forensic case? My thoughts were 
interrupted by his outburst. 
"Hello, I'm Dr. the staff psychiatrist. You 
must be the new medical student." 
Things didn't go so well during this rotation, 
although I must admit we did see a number of 
interesting patients. There was a fellow who thought 
he could identify different neighbourhoods and cities 
by their characteristic sounds and gave beautiful 
descriptions of the music in the air composed of city 
noises . There was a fellow who was trying to 
enumerate the number of ants in Canada. "I know it 
by W. David Colby, MSc, MD, FRCP(C) 
ounds strange, but there i a way to do it!" Another 
one thought he was Jesus Christ and assigned biblical 
roles to all the significant people in his life. What he 
worried about was having to relive the crucifixion scene 
since it was so rough the first time. I felt quite sorry for 
him. My favourite was this fellow who sat around all 
day in a black depression doing nothing but moping 
around the house and watching television. "What kind 
of shows do you watch?", I asked. 
"Happy Days", he replied . He went on to describe 
how he finally decided to end it once and for all by 
slitting his throat with a butcher knife. " ... and I laid 
down and waited to die", he said, " ... but I didn't die, so 
I called the ambulance." 
"Why did you call the ambulance if you wanted to 
die?", said the other clinical clerk. '"Cause I didn't 
want to get an infection, you stupid idiot." 
I just couldn't do anything right as far as my staff 
psychiatrist was concerned. At the end of the year, he 
kicked me out with one point above a bare PASS level. 
Needless to say, the very next week my first rotation as 
a clinical clerk at another hospital was in Psychiatry, 
and with the same approach and skills, I achieved the 
highest grade awarded that year on that service. Most 
of the staff psychiatrists were very interesting and had 
genuine, deep insight into the human mind. My 
favourite was an elderly fellow whom I will call 
" utty". During his prime, he had achieved 
considerable fame for his skills as a diagnostician and 
therapist and even in his post-retirement capacity- this 
guy missed nothing. He may have achieved this insight 
by spending long periods of time as an inpatient on the 
Psychiatry Service where he worked. Whenever he felt 
that he was losing it, he would conveniently admit 
himself under himself, write his own orders and treat 
himself until he felt he should be discharged, all the 
while leaving his bed periodically to do rounds on his 
other inpatients on the same service! I left that service 
with great reluctance because, unlike my experience at 
Queen Street, I had learned a great deal. Unfortunately, 
I also learned about the most unpleasant type of 
psychiatric patient-one whose mere mention sends 
chills up the spine of any practicing psychiatrist: the 
borderline personality disorder. 
Patients with borderline personality disorder seem to 
have been placed on this earth for a specific mission: to 
make the lives of their therapists miserable. They are 
equipped with every nasty psychological trick in the 
book: sharply opinionated nature, exaggerated 
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emotional responses and an ability to incite conflicts 
wherever they go. Many of these people, of course, end 
up serving in public office. I will present a brief case 
history of a typical patient which I saw in my phase of 
being an Emergency physician. 
I looked down on the chart and saw that the chief 
complaint of this patient was "wants to talk to a 
doctor" . I knew that spelled trouble. It wasn' t a good 
day anyway as I had 75 patients backed up in the 
waiting room. Nevertheless, I dusted off my best 
"doctor-patient relationship hat'' , put it on and went in 
to see the patient. She was a nurse in her early 60s. 
"Hello, Mrs. I'm Dr. Colby. What is 
troubling you today?" 
"You' re the doctor. You tell me! " , she sneered 
through a Medusa's breath of venom. 
"Oh, no!", I thought, " .. .1 can' t stand it. Furthermore, 
I don' t have time for this." Nevertheless, the patient 
went on a long rambling narrative about how she had 
been prematurely widowed, had been alone for many 
years but had presented to the Emergency Room 
because she now had a boyfriend who cared about her. 
"Say what?" , I thought. "Are you having a problem 
with your relationship?", I asked. 
"Of course I am!", she screamed. "The relationship 
has progressed to the point of where it ' s ge tting 
physical and it makes me nervous. Do something about 
it!" 
Great. An emotional adolescent lands on my 
doorstep expecting long-term psychotherapy to start in 
the middle of the busiest afternoon in my life and is 
hostile besides. I considered handing in my resignation 
and walking out but I thought I could probably be sued 
somehow for this. Just when I was about to sign myself 
in as a patient, what did I hear but the voice of the 
consulting psychiatrist on call, walking by just outside 
the confines of the Emergency cubicle. I shoved my 
hand through the curtains, found a lapel and dragged 
him in . "Dr. , I'd like you to meet Mrs. 
Jason Bowels M.D.. suraical Resident 
This ~-Tt-aitti., 
is i"'po.-tah~ 
for- "tht. Soci•1 
_____ _ . She has a problem and I would like to 
refer her to you." This was a classic dump, elegantly 
executed. The timing couldn't have been better. A few 
patients later, I noticed out of the corner of my eye Mrs. 
________ sashaying out of the hospital with a 
prescription in her hand. I was then summoned to the 
other hospital in town since there had been a multiple 
motor vehicle accident resulting in a large number of 
critically injured patients suddenly arriving at the 
Emergency Room and overwhelming the staff there. I 
jumped into the car and roared across the river to the 
other hospital and attended a few of these unfortunate 
accident victims. While I was writing at the chart desk, 
whom should I see but Mrs. coming in, 
soaking wet, on a stretcher. The ambulance attendants 
said that she jumped off the bridge and was fished out 
of the river by a couple of guys angling from a boat. 
"I'll handle this", I said to the chart clerk, and I 
followed Mrs. as they wheeled her into 
the room. "Mrs. why did you do this?" 
"You should have seen the signs!", she hissed. "I'm 
ready to be taken to my room now." She looked away. 
I got the picture. This was an act of revenge for not 
admitting her in the first place. 
"But I did see the signs, Mrs . ", I 
explained . "That' s why I referred you to Dr. 
"Shut up and take me to my room", she said. 
"I'll see to that when I can", I said icily and left her to 
chill out for about 20 minutes . When I returned, I 
informed that I had to do her admission physical. 
While I was examining her, she suddenly put a satisfied 
and triumphant look on her face. To my horror, I 
realized that she had purposely voided her bladder and 
bowels in order to make my job more unpleasant. 
Borderline personality disorder. 
It was at this point that I gave up any aspirations of 
being a psychiatrist, forever. 
We.. hcl~ +o 
trai.,.. '1o"'-
li~ Cl~~ 
By Dr. Michael Rieder 
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L i fegifts: 
Organ 
The Real Story 
Transplants 
of 
Calvin R. Stiller. 230 pp., illustrated. Toronto, Ont., 
Stoddart Publishing Co. Limited, 1990. $14.95. 
ISBN 0-7737-2301-3. 
D r. Calvin Stiller's Lifegifts focuses on the sad irony surrounding organ transplants: one person's tragedy is another's good fortune. He 
juxtaposes informational chapters about the state of 
organ transplantation with anecdotal chapters that allow 
the reader a glimpse of the complex emotions and issues 
at the time of organ donation. This method of writing 
allows Dr. Stiller to accomplish his goal "to help the 
general public better understand the process and current 
potential of transplantation while grasping the 
correctable tragedy of wasted donor organs." 
Dr. Stiller begins his discussion of the state of the art 
in transplantation technology with a brief history of 
organ transplantation. He simply and eloquently 
describes the immune system, the problem of rejection in 
transplants, and the effects of the introduction of 
cyclosporine in 1978 on the success rates of various 
procedures. Using a heart transplant as an example, Dr. 
Stiller goes on to describe in fair detail the actual 
technique in an organ transplant operation, and the 
drama and sense of urgency throughout the procedure. 
Despite his attention to detail, the discussion is absorbing 
and the explanations are accessible to the reader with no 
medical training. 
Far more important than the explanations about 
technique or infrastructure is the author's discussion 
about the attitudes and misconceptions on the part of the 
Jason Bowels M.D.. Sun!ical Resident 
5 lAY"~-tr-~ Tea..,-
lhe (ni..r s+tr of 
l-\ e~ tt~ hAs ~e~ 
hit by dear -
go to E. f... S~~ .~ 
by Sonny Bhalla 
public and the medical community. Public education, 
Dr. Stiller asserts, is essential to raise the percentage of 
organs that are actually isolated and used. 
A part of what makes this book so accessible to the 
nonmedical reader is the author's willingness to 
acknowledge the imperfections of the medical 
community. Hesitancy on the part of physicians is a 
significant obstacle that must be overcome before organ 
transplantation achieves its full potential. Too often, 
physicians view transplantation as an experimental 
approach carried out in a few select sites across the 
country. Nothing could be further from the truth; most 
organs are transplanted with a full functional recovery 
rate of 70-75% or better. Doctors must be educated. 
"Traditionally, doctors have been taught that their 
responsibility for the patient ends at death." 
Dr. Stiller is not afraid to comment on some of the 
highly charged issues surrounding organ transplants. 
Finally, Dr. Stiller discusses his vision for the future of 
organ transplantation, and the obstacles that must be 
overcome before we can finally cut short the tragic waste 
of usable organs, and the consequent death of those who 
desperately need them. 
Overall, Lifegifts is a short, readable book that 
concisely outlines the technological and psychosocial 
issues regarding organ transplantation. The fact that Dr. 
Stiller is acutely aware of the intense and often 
conflicting emotions on the part of those considering 
donation endears him to the reader, and therefore makes 
his important message that much more effective. 
n 
By Dr. Michael Rieder 
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THINKING ON YOUR FEET 
"Thinking On Your Feet" is an exercise designed to test your clinical decision-making skills based on a case 
presentation. Below is an exciting patient history with physical examination and laboratory results. Answers may be 
found on page 53 & 54 or within the case itself. Although this section is called ''Thinking On Your Feet," thinking is 
acceptable in any position. Answer the questions in sequence. Please do not peek at the answers prematurely-this 
would not be ethical. Compare your responses with those of the case presenter. Award yourself one point for each 
match. 
Scoring: 
Excellent. Patient is recovering nicely; 85-100% 
72-84% 
59-71 % 
40-58% 
0-39% 
Strong Work. Patient is recovering-minor complications; 
Good Eye. Patient likely to survive-some disfigurement; 
Fair. Patient requires critical care & close monitoring; 
Uh-Oh. Red alert-emergency crisis-check A-B-C's. 
A CHILD WITH RECURRENT INFECTIONS 
A nine year old girl presents with a diffuse papilliform 
erythematous rash involving her trunk and extremities 
includure her palms and soles. She is on treatment with 
Septra for persisting, festering open sores on her 
extremities, vulva and lower abdomen. Further history 
reveals she had a severe pneumonia four months before 
for which she was treated with antibiotics and 
hospitalized for two weeks. She has had many previous 
episodes of ear, sinus and chest infections since two years 
of age but have been worst in the past year. She was born 
with a congenital heart lesion and had open heart surgery 
at one year of age. She was fully immunized, had no 
delay in reaching her milestones and her height and 
weight are on the 50th percentile. 
STOP PLEASE AND ANSWER THESE QUESTIO S: 
1. What specific family history do you want to ask? 
2. Which physical findings may you expect to detect? 
PLEASE CONTINUE ... 
On examination she is afebrile and in no acute d istress. 
The erythematous rash is noted. She has numerous scars 
and scabs on her legs and lower abdomen. There is 
thrush in her oropharynx and she has only some minor 
cervical lymphadenopathy. Her liver is palpabl 3 em 
below the right costal margin and her spleen tip is also 
easily palpable. She has a fixed splitting second heart 
sound heard over her pulmonic area. The rest of her 
examination is unremarkable. 
STOP PLEASE AND ANSWER THESE QUESTIO S: 
3. What is your clinical diagnosis at this point? 
4. What is your differential diagnosis? 
5. Which laboratory investigations would be indicated? 
6. What intervention would you offer this patient? 
CONTINUES TO SUPPORT HOSPITAL PHARMACY 
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50 
------------------------ U.W.O. Medica/Journal 63 (1) 1993 
Problem Solving 
MEDICAL VOCABULARY 
This section is designed to test and expand your knowledge of medical 
terminology. How many items can you correctly define? 
Scoring: [13-lS]=Superior knowledge, [10-12]=Above average, [8-9]=Adequate, [5-7]=Fair, [1-4]=Sub-par. 
1. Refsum's Disease. 
a) a ganglio ide storage disease producing a distinct maple 
syrup odour to the urine; 
b) th e di ea se complex which occu rs seconda ry to 
pinworm infection; 
c) a ra re degenera t ive disease o f aging, co m monly 
involving the speech centres initially; 
d) an a u tosoma l recessive, degenerative disorder 
associated with retinitis pigmentosa, deafness, and 
polyneuritis. 
2. Indolent. 
a) rude and insulting; 
b) inactive, sluggish; 
c) treacherous, stealthy; 
d ) insensible, unconscious. 
3. Peristrumitis. 
a) inflammatory condition of tissues around a goitre; 
b) inflammation of a tendon sheath; 
c) infla m ma t ion of m embra nes a ro und a s inus , 
especially a venous sinus of the dura mater; 
d ) inflammatory condition of the ex ternal layer of a 
vein. 
4. Frottage. 
a) french cottage cheese; 
b) the p u trid od ou r produced from the collec tive 
decomposition of many corpses; 
c) production of sexual excitement by rubbing against 
someone; 
d) reaking havoc. 
5. Oxyecoia. 
a) having a sharp, pointed nose; 
b) a genus of amoebas found in the intestinal tract; 
c) excess of oxalate deposited in tissues; 
d) abnormal sensitivity to noises. 
6. Coprophilia. 
a) attraction of microorganisms to fecal matter; 
b) a psychiatric term denoting a morbid attraction and 
interest in fecal matter; 
c) the attraction of s pe rmatozoa to coppe r- the 
principle behind copper wire intrauterine devices; 
d ) (a) & (b). 
7. Proemial. 
a) a late occurrence of a disease process; 
b) refer r ing to a n ea rly s ta ge of e mbryologic 
development; 
c) prodromal; 
d ) maliormation of the prosencephalon. 
8. Symphalangism. 
a) the most anterior point of the alveolar p rocess of the 
lower jaw; 
b) web-fingered or web-toed condition; 
c) excessive peripheral vascular tone due to sympathetic 
dysfunction; 
d) surgical repair of a divided symphysis. 
Medicine 
Get the facts about the challenge and oppor· 
tunity of the Canadian Forces Medical Officer 
Training Plan. 
Students of medicine, male or female, 
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Problem Solving 
9. Trephination. 
a) a long, hollow tube through which sounds are resonated 
great distances; 
b) the process of boring a hole in any flat bone, especially 
the patella, to allow escape of pus; 
c) a reconstructive surgical technique whereby a piece of 
bone is remodelled; 
d) removal of a circular peice of cranium by a trephine. 
10. Hedrocoele. 
a) accumulation of serous fluid in the tunica vaginalis testis; 
b) a downward displacement of the caecum; 
c) a small bullous rising of the skin which contains serous 
fluid; 
d) a hernia or porlapse through the anus. 
11. Bruxism. 
a) clenching and grinding of teeth, usually during sleep; 
b) spasm of masticatory muscles; 
c) pain secondary to malocclusion of the teeth; 
d) partial paralysis of the upper palate due to inferior 
alveolar nerve damage. 
12. Egilops. 
a) a Freudian term referring to an unbalanced psyche; 
b) an obsolete term for a swelling at the inner canthus of the 
eye; 
c) an inability to resist sexual impulses; 
d) (a) & (c). 
13. Progeria. 
a) premature senility syndrome; 
b) the syndrome of continuous endometrial sloughing due 
to an absence of progesterone; 
c) the constellation of signs and symptoms due to excess 
progesterone-weight gain, headache, edema, and 
depression; 
d) the manifestion of infantile behaviours associated with 
senile dementia . 
14. Kerley Lines. 
a) thickening of interlobular lung septa seen on a chest x-
ray; 
b) transverse folds of the mucous membrane of the small 
bowel; 
c) growth bands in the dentin of a tooth; 
d) lines extending from the upper limit of the obturator 
foramen to the middle of the neck of the femur, seen on 
an x-ray of the hip. 
15. Betel Nut. 
a) the nut of the areca palm tree chewed by natives of the 
East Indies; 
b) an extract from the cytoskeleton of the South American 
Piper Beetle-used as a soporific agent; 
c) an Indian delicacy, derived from the giant red-haired 
beetle, indiginous to the Himalaya mountains; 
d) a slang indicating testicular inflammation; a condition 
restricted to men with a hereditary deficiency of the 
enzyme which metabolizes betacyanin, a byproduct of 
beet ingestion. 
London Regional Cancer Centre 
The UNIVERSITY of WESTERN ONTARIO 
Faculty of Medicine • Department of Oncology 
790 Cannissians Road East, Laldon, c:ntario N6A 4L6 (519) 685- 8600 
Dr. Leslie Levin, MD, FRCPC, 
Chief Executive Officer, 
London Regional Cancer Centre, 
Profe sor & Chairman, 
Department of Oncology 
The London Cancer Centre is a modem, 
well-equipped, ambulatory treatment facility . 
The opportunity exists to participate in 
clinical and basic research programs. 
The Department of Oncology offers 
postgraduate training in Medical 
and Radiation Oncology. 
For details, contact: 
Dr. Walter Kocha, MD, FRCPC, 
Training Program Director, 
Department of Medical Oncology 
(519) 685-8638 
Dr. Andrew Cooke, MD, FRCPC, 
Training Program Director, 
Department of Radiation Oncology 
(519) 685-8650 
The Ontari o Cancer Tr e atment & Research Foundation 
MILESJIA 
SERVING YOU BEST 
... through people, 
research and innovation. 
MILES CANADA INC. 
Pharmaceutical Division 
n Belfield Road, 
Etobicoke, Ontario MfJN 1G6 
52 
------------------------ U. W.O. Medical Journal 63 (1) 1993 
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to be a parent before you're ready. 
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So take care. Be well informed and protect 
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P r oblem Solving 
ANSWERS TO CASE STUDY 
1. It appears this child is having an unusual problem with 
frequent infections and possibly drug intolerance to 
SeptraR. If she has an immunodeficiency it may be 
congenital or acquired. Since congenital 
immunodeficiencies may be familial, the parents 
hould be asked whether there exists a family history 
of recurrent infections. The majority of children with 
AIDS were infected pre or perinatally by their mothers. 
The maternal history of known HIV infection or 
recurrent infections is especially pertinent. 
2. Congenital immunodeficiencies may be part of 
syndromes manifesting with dysmorphic features (eg. 
DiGeorge Syndrome of micrognathia, brachial clefts 
and congenital heart disease). Children with recurrent 
or chronic infections may have persistent stimulation 
of their reticuloendothelial system and thus display 
hepatosplenomegaly and I or generalized 
lymphadenopathy. They may also suffer signs of 
persistent mucosal infections such as thrush 
(Candidiasis) and herpetic lesions. 
3. The history and physical examination are suggestive of 
recurrent infections due to an underlying 
immunodeficiency. 
4. The immunodeficiencies can be categorized into T cell 
disorders; B cell disorders; combined T and B cell 
disorders; neutrophil and complement deficiencies. 
These may be congenital or acquired. This child seems 
to have been getting progressively worse since late 
infancy, although the exact time of onset of an 
abnormal frequency and severity of infections is 
difficult to establish. A major clue is the open heart 
urgery which invariably requires blood transfusions. 
The Red Cross started screening blood products in the 
Fall of 1985. Hence, this child was possibly exposed to 
HIV contaminated blood and HIV infection should be 
near the top of the differential diagnosis. Furthermore, 
SeptraR intolerance is more common in HIV infected 
patients. 
5. A CBC and differential will indicate the numbers of 
circulating neutrophils and lymphocytes, most of 
which are T lumphocytes. However, the CD4 cells, a 
subset of T lumphocytes which are usually decreased 
in symptomatic HIV infections, may be severely 
depressed in the presence of a normal circulating 
lymphocyte count. Hence, the CD4 count should be 
assessed specifically by flow cytometry. Her HIV 
antibody status should be determined. Her total and 
pecific immunoglobulin levels should also be 
measured. A CH50 level which determines 
complement activity is an appropriate screen for most 
complement deficiencies resulting in 
immunosuppression. This child was found to be HIV 
infected, had a low normal lymphocyte count and a 
CD4 count of 400 which is below the normal level for 
her age. Her immunoglobulin profile demonstrated 
polyclonal stimulation with a marked increase in her 
IgM. 
. .. continued on page 54 
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6. As one would expect, the aproach to a patient with 
immunodeficiency is to treat the current opportunistic 
infection with appropriate anti-infectives while 
attem§.ting to correct the underlying disorder. The 
Septra should be discontinued and if the impetiginous 
lesions relapse they should be cultured. Cloxacillin 
constitutes the antibiotic of choice since these infections 
are u ually caused by Group A Streptococci and 
Staphylococcus au reus. Oral ketoconazole or fluconazole is 
usually required to treat mucosal candidia is in HIV 
infected patients. Consideration should be given to 
tarting anti-retroviral therapy ince the CD4 count is less 
than 500. Lastly, intravenous immunoglobulin is 
recommended for chilfren with symptomatic HIV and 
dysgammaglobulinernia to reduce the frequency and 
severity of recurrent infections. 
ANSWERS TO VOCABULARY 
1. Refsum's Disease. (d) Heredopathia A tactica 
Polyneuritiformis. A rare degenerative disorder 
transmitted as an auto omal recessive trait and caused 
by an absence of phytanic acid alpha-hydroxyla e. The 
disease is characterized by retiniti pigmentosa, 
polyneuritis, deafnes , nystagmus, and cerebellar igns. 
2. Indolent. (b) Inactive; sluggish; painles or nearly so-
said of a morbid process. 
3. Peristrumitis. (a) Inflammation of the tis ues around a 
goitre. 
4. Frottage. (c) The rubbing movement in rna age; 
production of sexual excitement by rubbing against 
someone. 
5. Oxyecoia. (d) An abnormal sensitivity to noises. 
6. Coprophoelia. (d) Attraction of microorganisms to fecal 
matter; In psychiatry, a morbid attraction to, and interest 
in (with a sexual interest), fecal matter. 
7. Proemial. (c) Prodromal; an early or premonitory 
symptom of a disease. 
8. Symphalangism. (b) Syndactyly; ankylosis of the finger 
or toe joints. 
9. Trephination. (d) Removal of a circular peice of cranium 
by a trephine, a cylindrical or crow saw used for the 
removal of a disc of bone, especially of the skull, or of 
other firm tissue as that of the cornea. 
10. Hedrocoele. (d) Prolapse of the intestine through the 
anus. 
11. Bruxism. (a) Clenching of the teeth, associated with 
forceful lateral or protrusive jaw movements, resulting 
in rubbing, gritting, or grinding together of the teeth, 
usually during sleep. 
12. Egilops. (b) Obsolete term for a swelling, absc ss, or 
fistula at the inner canthus of the eye. 
13. Progeria. (a) Hutchinson -Gilford Disease. Premature 
senility syndrome; a condition in which normal 
development in the first year is followed by gross 
retardation of growth, with a senile appearance 
characterized by dry, wrinkled skin, total alopecia, and 
bird-like facies. 
14. Kerley Lines. (a) Markings on chest roentgram 
representing thickening of interlobular septa, due to 
pulmonary edema or cellular infiltration. 
15. Betel Nut. (a) Areca Nut. The nut of the areca palm 
(Areca Catechu) chewed by natives of the East Indies; the 
nut is so-called because it is chewed with dried Piper 
Betle leaves (an East Indian red pepper plant used as a 
stimulant and narcotic). 
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VITAMIN E UPDATE 
Vitamin E (alpha-tocopherol) has 
been the subject of many recent 
publications that have attracted 
much attention from both the 
medical profession and the lay press. 
Vitamin E, a primary lipid-soluble 
antiox idant, is a membrane 
consti tuent of the heart myocy te 
where it plays an acive role in 
countering oxidative stress. In 
addition, vitamin E may prevent the 
oxidation of lipoproteins since the 
atherogenic potential of lipoproteins 
increases when oxidized1• 
Vitamin E deficiency may be a 
risk factor for heart disease. Further, 
adequate levels of vitamin E may 
prevent the progression of 
atherosclerosis 2• Many current 
studies are based on the hypothesis 
that therapeutic vitamin E (or its 
analogues) may protect the heart 
from progressive ischemic injury3·•. 
As well, research on peripheral 
vascular disease indicates that 
vitamin E may have a positive effect 
on intermittent claudication5• 
1 Free Radical Biology and Medicine. 11(1):129-44 
(1991). 
2 japanese journal of Clinical Medicine. 51(4):997-
1003 (I 993). 
3 Canadian journal of Cardiology . 9(1):89-93 
(1993). 
4 Free Radical Biology and Medicine. 10(5):315-24 
(1991). 
5 European juornal of Clinical Pharmacology. 
37(6):541-4 (1989). 
PBLPROP06ALPE~D 
Newly appointed Associate 
Dean Lloyd has released a 
document proposing that the Faculty 
of Medicine move to a PBL-based 
curriculum. McMaster University, 
Calgary, Toronto, Ottawa, and 
Dalhousie now all have curricula 
whose mainstay is PBL. Soon 
classroom teaching could become a 
thing of the past. As to whether or 
not this new trend in teaching is 
going to make a difference - well, 
only time will tell. 
SIDE EFFECTS 
CONCEALED FROM THIRD 
WORLD PATIENTS 
According to the current issue of 
The New Physician (vol 42(6):9), a 
growing number of U .S.-based 
m ultina tiona I pharmaceutic a I 
companies are selling drugs with 
incomplete information labels to 
developing countries. In a study 
done by the U .S. Office of 
Technology Assessment (OT A), two-
thirds of a random ample of 241 
drugs failed to provide information 
about the side effects of the drugs. 
For example, one of the drugs being 
sold overseas was an anti-
inflammatory drug that was taken 
off the U.S. market because it caused 
a fatal leukopenia . The OT A 
suggests "the implementation of an 
international code of conduct for 
pharmaceutical labelling" to prevent 
further abuses, since there are no 
U.S. labelling laws encompassing 
drugs being produced and marketed 
by a foreign subsidiary of a U.S. 
company. 
BITTER TASTE IN YOUR 
MOUTH? 
The bitter taste of certain foods 
and drugs may become a thing of the 
past. A specific lipoprotein made of 
phospha tidic acid and IS-
lactoglobulin, abbreviated PA-LG, 
reportedly binds to tongue receptors 
for bitter substances. A high 
concentration of PA-LG appears to 
suppress the bitter taste sensation in 
humans while leaving other taste 
sensations unchanged. Phosphatidic 
acid and IS-lactoglobulin are 
produced from soya beans and milk 
respectively. PA-LG may soon be 
used to fight bitterness in taste buds 
everywhere. 
[Katsuragi et al., Nature. 365:213-
214 (1993).] 
PARTICLE ACCELERATOR 
TO FIGHT CANCER 
Construction of the world's first 
medical accelerator is nearing 
completion in Japan. The 300 million 
dollar Heavy-Ion Medical 
Accelerator in Chiba (HIMAC) was 
designed for use in cancer therapy. 
HIMAC is expected to offer 
cancer treatment programs by March 
of 1994. Heavy-ion therapy involves 
bombarding patients with an 
assortment of ions like neon, carbon 
and silicon. 
Heavy ion therapy is gaining 
interest for two reasons: First, the 
mass and charge of heavy ions gives 
these ions stronger tumour-
destroying capabilities than 
radiation therapy. Second, heavy ion 
bombardment is more tumour-
speciifc than radiation therapy. In 
addition, aim of the charged ion 
beam can be finely adjusted using 
electromagnetic fields, and the ions 
release most of their destructive 
energy at the end of their path. 
The disadvantages to this form of 
therapy are high cost and rela tive 
ineffectiveness against metastases. 
HIMAC offers an alternate form 
of cancer treatment with potentially 
less side effects than present 
treatment regimens. [Science. 
261:1270 (1993)] 
BENEFITS OF SMOKING 
IGNORED 
Cigaretted smoking may be 
protective for a number of diseases, 
but reasearchers, granting agencies, 
pharmaceutica l firms, and eth ics 
comittees are reluctant to promote or 
permit investigation into the area . 
"People do not want to be seen to 
promote smoking in any way, " 
according to an article inNew 
Scientist magazine. Nevertheless, 
some evidence for benefits 
attributable to smoking exists in 
Parkinson's, Alzheimer's, ulcerative 
colitis, rheumatoid arthritis, and 
even some cancers! 
[Mundell, I. New Scientist. 
9 October 1993, pp. 14-15.] 
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